NVIDIA ANNOUNCES UPCOMING EVENTS FOR FINANCIAL COMMUNITY

News

santa clara, calif., nov. 21, 2024 (globe newswire) -- nvidia will present at the following events for the financial community: ubs global technology and ai conference tuesday, dec. 3, 6:35 a.m.

KAIXIN HOLDINGS EXPLORES STRATEGIC ALTERNATIVES WITH POTENTIAL ACQUISITION IN CRYPTO MINING SECTOR

News

hangzhou, china, nov. 14, 2024 (globe newswire) -- kaixin holdings (“kaixin” or the “company”) (nasdaq: kxin) today announced a major strategic step forward as it explores new growth avenues. in the advanced stages of evaluating strategic alternatives, kaixin is actively considering the acquisition of a controlling equity interest in a leading cryptocurrency mining company based in the middle east. this mining company operates with cost-efficient btc mining machines, optimizing self-mining processes while also offering sophisticated, end-to-end cloud hosting services tailored to meet the growing demand within the crypto mining industry. the facility's long-term, stable energy supply is a critical asset that bolsters operational resilience and cost efficiency, underscoring kaixin's commitment to sustainable and profitable growth.

MOMENTUS RECEIVES HALO PROTOTYPE ORDER CONTRACT FROM SDA

News

san jose, calif.--(business wire)--momentus inc. (nasdaq: mnts) (“momentus” or the “company”), a u.s. commercial space company that offers satellite buses and technologies, transportation, and other in‑space infrastructure services, today announced that it has been awarded a contract from the u.s. defense department's space development agency (sda) for the hybrid acquisition for proliferated leo (halo) program. sda has been tasked with deploying a constellation of several hundred satellites in.

MICROCLOUD HOLOGRAM INC. ANNOUNCES RESULTS OF ITS 2024 ANNUAL GENERAL MEETING OF THE SHAREHOLDERS

News

shenzhen, china , oct. 2, 2024 /prnewswire/ -- microcloud hologram inc. (nasdaq: holo), (the "company"), today announced that its 2024 annual general meeting of the shareholders (the "agm") was duly held on september 27, 2024, at the company's headquarters in shenzhen, china. at the agm, the following proposals were approved and adopted: that every 20 issued and unissued ordinary shares of a nominal or par value of us$0.001 each in the capital of the company (the "ordinary shares") be consolidated into one (1) share of a nominal or par value of us$0.02 each, and such consolidated shares shall rank pari passu in all respects with each other in accordance with the company's currently effective memorandum and articles of association (the "share consolidation") such that following the share consolidation the authorized share capital of the company will be changed from us$500,000 divided into 500,000,000 shares of a nominal or par value of us$0.001 each to us$500,000 divided into 25,000,000 shares of a nominal or par value of us$0.02 each (the "consolidated ordinary shares") to consider and vote upon an ordinary resolution to increase the company's share capital after the share consolidation: that conditional upon and effective immediately following the share consolidation, increase the authorized share capital of the company from us$500,000 divided into 25,000,000 consolidated ordinary shares, to us$10,000,000 divided into 500,000,000 consolidated ordinary shares (" share capital increase "), by the creation of an additional 475,000,000 consolidated ordinary shares to consider and vote upon a special resolution to delete the existing article 15.6 of the company's currently effective amended and restated memorandum and articles of association (the "current m&a") in its entirety and the substitution therefor the following: "an appointment of a director may be on terms that the director shall automatically retire from office (unless he has sooner vacated office) at the next or a subsequent annual general meeting or upon any specified event or after any specified period in a written agreement between the company and the director, if any; but no such term shall be implied in the absence of express provision.

INTEL ANNOUNCES RETIREMENT OF CEO PAT GELSINGER

News

santa clara, calif.--(business wire)--intel corp. announced that ceo pat gelsinger has retired from the company and stepped down from the board of directors, effective dec. 1, 2024.

MULLEN ANNOUNCES PAPÉ AND EMERALD TRANSPORTATION'S REFRIGERATED SOLUTION FOR THE MULLEN CLASS 3 EV TRUCK

News

emerald is a leading commercial vehicle manufacturer and seller of refrigerated trucks and vans the refrigerated class 3 ev box truck opens new rapidly expanding categories for home delivery, frozen food, grocery and beverage transportation brea, calif., nov. 26, 2024 (globe newswire) -- via ibn -- mullen automotive, inc. (nasdaq: muln) (“mullen” or the “company”), an electric vehicle (“ev”) manufacturer, announces today that emerald transportation solutions (“emerald”), a premier commercial refrigeration (“reefer”) vehicle upfitter, is working with the papé group (“papé”) to develop an advanced reefer upfit for the mullen three, a class 3 all-electric truck.

BROADCOM INC. TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON THURSDAY, DECEMBER 12, 2024

News

palo alto, calif. , nov. 12, 2024 /prnewswire/ -- broadcom inc. (nasdaq: avgo), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its fourth quarter and fiscal year 2024 financial results and business outlook on thursday, december 12, 2024 after the close of the market.

HYZON ANNOUNCES SUCCESSFUL TRIAL COMPLETION OF NORTH AMERICA'S FIRST FUEL CELL POWERED REFUSE TRUCK WITH MT. DIABLO RESOURCE RECOVERY

News

further demonstrates hydrogen fuel cell technology as a sustainable, zero-emission solution for heavy duty applications bolingbrook, ill. , nov. 14, 2024 /prnewswire/ -- hyzon (nasdaq: hyzn) (hyzon or the company), a u.s.-based, high-performance, hydrogen fuel cell system manufacturer and technology developer focused on providing zero-emission power to decarbonize the most demanding industries, today announced the completion of a successful trial of its refuse collection fuel cell electric truck (fcet) -- developed in partnership with new way trucks -- with mt.

VOCODIA ENTERS MEDICAL ALERT INDUSTRY WITH INNOVATIVE EMERGENCY RESPONSE PENDANT

News

boca raton, fla. , oct. 25, 2024 /prnewswire/ -- (otcmkts: vhai) vocodia, a leader in artificial intelligence and communication technologies, proudly announces its entry into the medical alert industry with the launch of its groundbreaking emergency response pendant.

AWS ANNOUNCES NEW DATA CENTER COMPONENTS TO SUPPORT AI INNOVATION AND FURTHER IMPROVE ENERGY EFFICIENCY

News

las vegas--(business wire)--at aws re:invent, amazon web services, inc. (aws), an amazon.com, inc. company (nasdaq: amzn), today announced new data center components designed to support the next generation of artificial intelligence (ai) innovation and customers' evolving needs. these capabilities combine innovations in power, cooling, and hardware design to create a more energy efficient data center that will underpin further customer innovation. these new capabilities will be implemented glob.

LOTUS TECHNOLOGY WINS GREEN APPLE AWARD FOR ENVIRONMENTAL PRACTICES

News

new york, nov. 29, 2024 (globe newswire) -- lotus technology inc. (“lotus tech” or “the company”) (nasdaq: lot), a leading global intelligent and luxury mobility provider, was awarded the green apple environment award for its commitment to sustainable environmental practices.

BANK OF AMERICA ANNOUNCES REDEMPTION OF $2,000,000,000 1.530% FIXED/FLOATING RATE SENIOR NOTES, DUE DECEMBER 2025

News

charlotte, n.c. , nov. 26, 2024 /prnewswire/ -- bank of america corporation announced today that it will redeem on december 6, 2024, all $2,000,000,000 principal amount outstanding of its 1.530% fixed/floating rate senior notes, due december 2025 (cusip no.

PSE, UPLIGHT PLUG TESLA IN TO EXPANDED HOME BATTERY PROGRAM

News

bellevue, wash., nov. 19, 2024 (globe newswire) -- puget sound energy (pse) and uplight, a clean energy technology company that helps consumers and energy providers conserve, manage, and monetize energy capacity, are excited to announce the expansion of their flex batteries program to include tesla home battery systems.

WARNER BROS. DISCOVERY, INC. INVESTOR ALERT: ROBBINS LLP REMINDS WBD STOCKHOLDERS OF THE PENDING SECURITIES CLASS ACTION

News

san diego, dec. 02, 2024 (globe newswire) -- robbins llp reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired warner bros. discovery, inc. (nasdaq: wbd) securities between february 23, 2024 and august 7, 2024.

ENDRA LIFE SCIENCES REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

News

ann arbor, mich.--(business wire)--endra life sciences inc. (nasdaq: ndra), an innovator of thermo acoustic enhanced ultrasound (taeus®), today announced that it has regained compliance with the minimum bid price requirement set forth by the nasdaq stock market llc (“nasdaq”). on november 21, 2024, the company received notification from the nasdaq listing qualifications department confirming its compliance with listing rule 5550(a)(2), thereby meeting nasdaq's maintenance requirements for listi.

VIZ.AI COLLABORATES WITH MICROSOFT TO ADVANCE AI-POWERED CLINICAL WORKFLOWS AND BETTER PATIENT CARE

News

san francisco--(business wire)-- #artificialintelligence--viz.ai, a leader in ai-powered disease detection and intelligent care coordination, today announced a collaboration with microsoft to deliver its ai models and care coordination solution with precision imaging network, part of microsoft cloud for healthcare. together, precision imaging network and viz.ai deliver a comprehensive solution with more than 48 ai models tightly integrated into clinical workflows, providing actionable clinical insights to help improve p.

MOTOROLA AND GOOGLE CLOUD BRING GENERATIVE AI TO NEW RAZR FAMILY OF SMARTPHONES

News

moto ai uses google cloud vertex ai with gemini and imagen models to give users an enhanced smartphone experience chicago and sunnyvale, calif. , june 25, 2024 /prnewswire/ -- motorola and google cloud today announced a new multi-year relationship to bring generative ai to motorola phones, including the brand new series of razr smartphones – starting with the brand new flagship motorola razr+/motorola razr 50 ultra.

CISCO TO HOST 2024 VIRTUAL ANNUAL MEETING OF STOCKHOLDERS

News

san jose, calif. , nov. 26, 2024 /prnewswire/ -- cisco (nasdaq: csco) will host its 2024 annual meeting of stockholders on monday, december 9, 2024, beginning at 8:00 a.m.

WELLS FARGO SUPPORTS DISASTER RECOVERY WITH $2 MILLION GRANT TO TEAM RUBICON

News

san francisco--(business wire)-- #community--the wells fargo foundation is donating $2 million to team rubicon over the next two years to support lasting disaster relief, including most recently in the hard-hit southeastern united states. this funding will enable thousands of volunteers, including military veterans, first responders and civilians to deploy quickly and for extended periods of time, providing critical support to communities as they rebuild. the veteran‑led humanitarian organization team rubic.

WET AGE-RELATED MACULAR DEGENERATION (WET AMD) PIPELINE LANDSCAPE RESEARCH 2024

News

dublin, nov. 22, 2024 (globe newswire) -- the "wet age-related macular degeneration (wet amd) - pipeline insight, 2024" report has been added to researchandmarkets.com's offering.

CHEETAH NET SUPPLY CHAIN SERVICE INC. ANNOUNCES THIRD QUARTER 2024 RESULTS AND PROVIDES CORPORATE UPDATE

News

irvine, calif., nov. 13, 2024 (globe newswire) -- cheetah net supply chain service inc. (“cheetah” or the “company”) (nasdaq cm: ctnt), a provider of warehousing and logistics, today reported results for the quarter ended september 30, 2024 and provided a corporate update.

NU HOLDINGS LTD. REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

News

são paulo--(business wire)--nu holdings ltd. (nyse: nu) (“nu” or the “company”), one of the world's largest digital financial services platforms, released its third quarter financial results today. financial results are expressed in u.s. dollars and are presented in accordance with international financial reporting standards (ifrs). the full earnings release has been made available on the company's investor relations website at www.investors.nu, as well as the details of the earnings conference.

ZAI LAB AND PFIZER ANNOUNCE STRATEGIC COLLABORATION ON THE NOVEL ANTIBACTERIAL DRUG XACDURO® (SULBACTAM-DURLOBACTAM)

News

shanghai & cambridge, mass.--(business wire)--zai lab (“zai lab”, nasdaq: zlab; hkex: 9688) and pfizer (“pfizer”, nyse: pfe) announced today a strategic collaboration for the novel antibacterial drug xacduro® (sulbactam-durlobactam) in mainland china. pfizer's affiliated companies will be exclusively authorized to undertake and perform certain commercialization activities for xacduro® in mainland china. through this collaboration, zai lab will leverage the industry-leading commercialization inf.

FARADAY FUTURE ESTABLISHES LOCAL SOURCING INITIATIVE IN RAS AL-KHAIMAH, UAE

News

los angeles--(business wire)--faraday future intelligent electric inc. (nasdaq: ffie) (“faraday future,” “ff,” or the “company”), a california-based global shared intelligent electric mobility ecosystem company, announced its commitment to local sourcing for manufacturing equipment in ras al-khaimah, uae. this strategic initiative aligns with the company's focus on fostering regional partnerships, streamlining logistics, and accelerating delivery timelines for its planned uae manufacturing oper.

PG&E CORPORATION ANNOUNCES LAUNCH OF CONCURRENT OFFERINGS OF COMMON STOCK AND MANDATORY CONVERTIBLE PREFERRED STOCK

News

oakland, calif. , dec. 2, 2024 /prnewswire/ -- pg&e corporation (nyse: pcg) ("pg&e" or the "company") announced today the launch of concurrent underwritten public offerings of (i) $1,200 million of shares of common stock, no par value ("common stock"), of the company and (ii) $1,200 million of newly issued series a mandatory convertible preferred stock ("preferred stock") of the company (together, the "offerings").

ROCKET LAB SIGNS $23.9M CHIPS INCENTIVES AWARD TO BOOST SEMICONDUCTOR MANUFACTURING

News

long beach, calif.--(business wire)---- $rklb--rocket lab signs $23.9m chips incentives award to boost semiconductor manufacturing.

OREA STATEMENT ON PROPOSED PRO-HOUSING SOLUTIONS IN THE FORD GOVERNMENT'S FALL 2024 RED TAPE REDUCTION PACKAGE

News

toronto, nov. 21, 2024 (globe newswire) -- “yesterday, the government of ontario introduced the cutting red tape, building ontario act, 2024 within their fall 2024 red tape reduction package, which, if passed, will provide better services, keep costs down, and bolster the economy.

TRUIST TO SPEAK AT THE GOLDMAN SACHS US FINANCIAL SERVICES CONFERENCE

News

charlotte, n.c. , nov. 21, 2024 /prnewswire/ -- truist financial corporation (nyse: tfc) today announced that chairman and chief executive officer bill rogers will speak at the goldman sachs 2024 us financial services conference at 10:40 a.m.

AT&T TO WEBCAST FIRESIDE CHAT WITH JOHN STANKEY AT THE UBS GLOBAL MEDIA & COMMUNICATIONS CONFERENCE ON DECEMBER 10

News

dallas , dec. 2, 2024 /prnewswire/ -- tune in for a fireside chat with john stankey at the ubs global media & communications conference, scheduled to begin at 8:15 a.m. et. webcast available live and for replay.

MARVELL EXPANDS STRATEGIC COLLABORATION WITH AWS TO ENABLE ACCELERATED INFRASTRUCTURE FOR AI IN THE CLOUD

News

aws expands supplier relationship with marvell for ai and data center connectivity products. marvell expands relationship with aws for electronic design automation (eda) in the cloud to deliver its silicon solutions.

WALMART LEADERSHIP TO PARTICIPATE IN UPCOMING INVESTOR EVENTS

News

bentonville, ark.--(business wire)--walmart inc. (nyse: wmt) announced today that company leadership will participate in upcoming investor events. links to those with live webcasts can be found on walmart's investor relations website at stock.walmart.com. dec. 3: morgan stanley global consumer & retail conference — doug mcmillon, president and ceo, will participate in meetings and the keynote fireside chat at 11:45 a.m. ct. this session will be webcast live through the “events” link at stoc.

MICRON TECHNOLOGY TO REPORT FISCAL FIRST QUARTER RESULTS ON DECEMBER 18, 2024

News

boise, idaho, nov. 21, 2024 (globe newswire) -- micron technology, inc. (nasdaq: mu) announced today that it will hold its fiscal first quarter earnings conference call on wednesday, dec. 18, 2024, at 2:30 p.m. mountain time.

THE SCHALL LAW FIRM URGES SHAREHOLDER PARTICIPATION IN AN INQUIRY INTO CSX CORPORATION FOR SECURITIES LAW VIOLATIONS

News

los angeles, ca / accesswire / december 1, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of csx corporation ("csx" or "the company") (nasdaq:csx) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

GLINDA AND ELPHABA WICKED COSTUMES ON DISPLAY AT THE COMCAST TECHNOLOGY CENTER

News

philadelphia--(business wire)--the signature costumes of glinda and elphaba, as worn by ariana grande and cynthia erivo in universal pictures' cinematic event wicked, are on display in the comcast technology center in philadelphia. universal pictures' wicked arrives in theaters november 22, 2024.

ONSEMI HYPERLUX SENSORS SELECTED FOR SUBARU'S NEXT-GENERATION AI-INTEGRATED EYESIGHT SYSTEM

News

scottsdale, ariz.--(business wire)--onsemi (nasdaq: on) announced today it will be the primary supplier of image sensors for subaru's next-generation eyesight stereo-camera front sensing system in future vehicle models. onsemi's advanced hyperlux ar0823at image sensor will serve as the “eyes” of the system, tailored to capture the critical visual data required to feed into subaru's stereo-camera enabled artificial intelligence algorithm that will allow the car to make more accurate driving deci.

MICROCHIP TECHNOLOGY UPDATES DECEMBER 2024 QUARTER REVENUE GUIDANCE, AND ANNOUNCES MANUFACTURING RESTRUCTURING PLANS

News

chandler, ariz., dec. 02, 2024 (globe newswire) -- microchip technology incorporated, a leading provider of smart, connected, and secure embedded control solutions, provided lower updated revenue guidance for the december 2024 quarter and announced manufacturing restructuring plans.

VERIZON DONATES $25,000 IN RESPONSE TO THE MOUNTAIN FIRE

News

irvine, calif., nov. 27, 2024 (globe newswire) -- in response to the mountain fire that burned through ventura county, verizon is reinforcing its commitment to the community with a $25,000 donation to the american red cross.

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF APPLIED MATERIALS, INC. - AMAT

News

new york, ny / accesswire / november 27, 2024 / pomerantz llp is investigating claims on behalf of investors of applied materials, inc. ("applied materials" or the "company") (nasdaq: amat). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.

PELOTON LAUNCHES NEW MULTI-PHASE CREATIVE CAMPAIGN TO DRIVE DEMAND AMONG NEW AUDIENCES

News

the first phase of the find your push. find your power.

NEXT-GENERATION ROBOTAXI PLATFORM UNVEILED, ROBOTAXI COMING TO UBER APP

News

new york, nov. 29, 2024 (globe newswire) -- weride inc. (“weride” or the “company”) (nasdaq: wrd), the world's first publicly traded robotaxi company and a global leader in the autonomous driving industry, today announced its unaudited results for the third quarter and nine months ended september 30, 2024. recent highlights after the successful listing on nasdaq, the company continued to make progress towards its long-term strategic objectives in the development of autonomous driving technologies and applications both directly and in partnership with others.

JOHNSON & JOHNSON SEEKS U.S. FDA APPROVAL FOR FIRST PEDIATRIC INDICATIONS FOR TREMFYA® (GUSELKUMAB)

News

applications filed for tremfya® to treat children with moderate to severe plaque psoriasis and active juvenile psoriatic arthritis  spring house, pa. , dec. 2, 2024 /prnewswire/ -- johnson & johnson today announced the submission of two supplemental biologics license applications (sblas) to the u.s. food and drug administration (fda) seeking approval of tremfya® (guselkumab) for the treatment of children 6 years and older with moderate-to-severe plaque psoriasis (pso) and children 5 years of age and older with active juvenile psoriatic arthritis (jpsa).a the pso submission is based on data from the phase 3 protostar study in pediatric patients with moderate to severe plaque pso and bridging pharmacokinetic (pk) data from the phase 3 voyage 1 and 2 studies in adult patients with moderate to severe plaque pso.

BEN BREAKING NEWS: FRANKLIN RESOURCES, INC. INVESTORS THAT SUFFERED LOSSES ARE ENCOURAGED TO CONTACT RLF ABOUT ONGOING INVESTIGATION INTO THE COMPANY (NYSE: BEN)

News

new york, dec. 02, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of franklin resources, inc. (nyse: ben) resulting from allegations that franklin resources may have issued materially misleading business information to the investing public.

NEWAMSTERDAM PHARMA PRESENTS ADDITIONAL DATA FROM PIVOTAL PHASE 3 BROOKLYN CLINICAL TRIAL EVALUATING OBICETRAPIB IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AT AHA SCIENTIFIC SESSIONS 2024

News

– met primary endpoint with ldl-c mean reduction versus placebo of 36.3% at day 84 and 41.5% at day 365 – – lp(a) mean reduction versus placebo of 45.9% at day 84 and 54.3% at day 365 – – total ldl-p mean reduction versus placebo of 52.5% at day 180, with small ldl-p reduction of 102.4% – – safety results comparable to placebo – naarden, the netherlands and miami, nov. 18, 2024 (globe newswire) -- newamsterdam pharma company n.v. (nasdaq: nams or “newamsterdam” or the “company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“cvd”) with elevated low-density lipoprotein cholesterol (“ldl-c”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced additional results from the company's phase 3 brooklyn clinical trial (nct05425745) evaluating obicetrapib in adult patients with heterozygous familial hypercholesterolemia (“hefh”), whose ldl-c is not adequately controlled, despite being on maximally tolerated lipid-lowering therapy.

SNOWFLAKE AND ANTHROPIC TEAM UP TO BRING CLAUDE MODELS DIRECTLY TO THE AI DATA CLOUD

News

no-headquarters/bozeman, mont.--(business wire)-- #thedatacloud--snowflake (nyse: snow), the ai data cloud company, and anthropic, an ai safety and research company, today announced a strategic multi-year partnership that will enable global enterprises to develop and scale easy, efficient, and trusted ai products, apps, and workflows powered by the latest state-of-the-art models. anthropic's newest claude 3.5 models will be available for users to securely leverage within snowflake cortex ai, snowflake's fully.

EQM MIDSTREAM PARTNERS, LP COMMENCES TENDER OFFER AND CONSENT SOLICITATION

News

offer to purchase for cash up to $1.275 billion aggregate purchase price for  6.500% senior notes due 2048, 5.500% senior notes due 2028,  4.50% senior notes due 2029 and 7.500% senior notes due 2030 solicitation of consents to proposed reporting amendments to the indentures governing 6.500% senior notes due 2048 and 5.500% senior notes due 2028 pittsburgh , nov. 25, 2024 /prnewswire/ -- eqt corporation (nyse: eqt) ("eqt" and, collectively with its subsidiaries, the "company") today announced that its indirect wholly owned subsidiary, eqm midstream partners, lp ("eqm"), has commenced a tender offer (the "tender offer") to purchase for cash eqm's outstanding 6.500% senior notes due 2048 (the "2048 notes"), 5.500% senior notes due 2028 (the "2028 notes"), 4.50% senior notes due 2029 (the "2029 notes") and 7.500% senior notes due 2030 (the "2030 notes" and, collectively with the 2048 notes, the 2028 notes and the 2029 notes, the "notes") for an aggregate purchase price, excluding accrued and unpaid interest, of up to $1.275 billion (the "maximum aggregate purchase price"). subject to the maximum aggregate purchase price, the amounts of each series of notes that are purchased will be determined in accordance with the acceptance priority levels set forth in the table below (the "acceptance priority levels"), with "1" being the highest acceptance priority level and "4" being the lowest acceptance priority level.

QUALCOMM SETS NEW GROWTH TARGETS, SHOWCASING COMPANY'S OPPORTUNITY AS ON-DEVICE AI ACCELERATES DEMAND FOR ITS TECHNOLOGIES

News

new york--(business wire)--qualcomm incorporated (nasdaq: qcom), a connected computing leader, today outlined its significant opportunities for growth and diversification at its 2024 investor day. the company's unique position at the edge is driving access to an expanded tam of approximately $900 billion by 2030, with more than 50 billion cumulative connected edge device shipments expected from 2024 through 2030. “qualcomm's focus on diversification and industry-leading technology roadmap has s.

SCHWAB TRADING ACTIVITY INDEX™: OCTOBER SCORE INCREASES SLIGHTLY AMIDST MIXED EARNINGS SEASON

News

westlake, texas--(business wire)--the schwab trading activity index™ (stax) increased to 48.37 in october, up from its score of 47.10 in september. the only index of its kind, the stax is a proprietary, behavior-based index that analyzes retail investor stock positions and trading activity from schwab's millions of client accounts to illuminate what investors were actually doing and how they were positioned in the markets each month. the reading for the four-week period ending october 25, 2024,.

CCL INDUSTRIES ANNOUNCES 2024 THIRD QUARTER RESULTS

News

third quarter highlights per class b share(3): $1.09 adjusted basic earnings up 14.7%; $1.08 basic earnings up 13.7%; currency translation negative $0.01 per share sales increased 9.4% on 6.9% organic growth, 1.8% acquisition growth and 0.7% positive currency translation ccl, avery, checkpoint and innovia posted organic sales growth of 4.9%, 3.0%, 14.5% and 18.0%, respectively operating income(1) improved 12.8%, with a 15.6% operating margin(1) up 50 bps nine-month highlights per class b share(3): $3.30 adjusted basic earnings up 18.3%; $3.72 basic earnings up 34.3%; $0.44 revaluation gain included in basic earnings; currency translation negative $0.01 per share sales increased 8.9% on 5.8% organic growth, 2.6% acquisition growth and 0.5% positive currency translation operating income(1) improved 15.7%, with a 16.1% operating margin(1) up 90 bps toronto, on / accesswire / november 13, 2024 / ccl industries inc. (tsx:ccl.a)(tsx:ccl.b)("the company"), a world leader in specialty label, security and packaging solutions for global corporations, government institutions, small businesses and consumers, today reported 2024 third quarter results. sales for the third quarter of 2024 increased 9.4% to $1,849.7 million compared to $1,690.5 million for the third quarter of 2023, with an organic growth rate of 6.9%, acquisition-related growth of 1.8% and a 0.7% positive impact from foreign currency translation.

HCLTECH COMPLETES ACQUISITION OF COMMUNICATIONS TECHNOLOGY GROUP ASSETS FROM HEWLETT PACKARD ENTERPRISE (HPE)

News

new york & noida, india--(business wire)-- #bss--hcltech today announced it has completed the purchase of certain assets from hewlett packard enterprise's (hpe) communications technology group (ctg).

CAVA TO PARTICIPATE IN MORGAN STANLEY GLOBAL CONSUMER AND RETAIL CONFERENCE

News

washington--(business wire)--cava group, inc. (nyse: cava), the category-defining mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, today announced that it will participate in the morgan stanley global consumer and retail conference on wednesday, december 4, 2024. brett schulman, co-founder and ceo, and tricia tolivar, cfo, will participate in 1x1 meetings and a fireside chat at 10:15 am est. the fireside chat and replay of the event will be available o.

CLEVELAND-CLIFFS COMPLETES ACQUISITION OF STELCO HOLDINGS INC.

News

hamilton, ontario--(business wire)--stelco holdings inc. (tsx: stlc) (“stelco” or the “company”) today announced that cleveland-cliffs inc. (“cliffs”) has completed its previously announced acquisition of stelco (the “arrangement”) pursuant to a plan of arrangement involving the company, cliffs, and 13421422 canada inc. (the “purchaser”), a wholly owned subsidiary of cliffs. alan kestenbaum, executive chairman and chief executive officer of stelco, stated: “over the past seven years, since the.

THE COCA-COLA COMPANY EVOLVES VOLUNTARY ENVIRONMENTAL GOALS

News

atlanta--(business wire)--the coca-cola company today announced updated voluntary environmental goals, which replace previous environmental goals set by the company related to water, packaging, climate and agriculture. this evolution is informed by learnings gathered through decades of work in sustainability, periodic assessment of progress and identified challenges. the updated goals aim to build long-term business resilience and make a positive impact in local communities. achieving these amb.

KENVUE ANNOUNCES PARTICIPATION IN THE MORGAN STANLEY GLOBAL CONSUMER & RETAIL CONFERENCE

News

skillman, n.j.--(business wire)--kenvue inc. (nyse: kvue) (“kenvue”) today announced the company's participation in the morgan stanley global consumer & retail conference in new york city. thibaut mongon, chief executive officer and paul ruh, chief financial officer will participate in a fireside chat on wednesday, december 4, 2024, at 11:45 a.m. eastern time. a live webcast of the fireside chat will be available on investors.kenvue.com and a replay will be available on the website followin.

KEYCORP TO PRESENT AT THE GOLDMAN SACHS FINANCIAL SERVICES CONFERENCE

News

cleveland , nov. 22, 2024 /prnewswire/ -- keycorp (nyse: key) announced today that chris gorman, chairman and chief executive officer, will speak at the goldman sachs financial services conference on tuesday, december 10, 2024, at 11:20 a.m. et in new york city.

BERRY GLOBAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF BERRY GLOBAL GROUP, INC. - BERY

News

new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of berry global group, inc. (nyse: bery) to amcor plc (nyse: amcr). upon closing of the proposed transaction, berry shareholders will own approximately 63% of the combined company. ksf is seeking to determine whether the transaction and the process that led to it are adequate, or whether the transaction is fair t.

DIAB CHAMBERS LLP, KAZEROUNI LAW GROUP AND THE DIXON FIRM FILE CLASS ACTION LAWSUIT AGAINST COMMONWEALTH EDISON AND EXELON CORPORATION FOR “DIRTY POWER”

News

chicago--(business wire)-- #dirtypower--the lawsuit seeks to ensure the utility industry adheres to established power quality standards, making it a significant matter of public concern.

GRAB REPORTS THIRD QUARTER 2024 RESULTS

News

singapore, nov. 11, 2024 (globe newswire) -- grab holdings limited (nasdaq: grab) today announced unaudited financial results for the third quarter ended september 30, 2024.

AMERICAN AIRLINES GROUP INC. (NASDAQ: AAL) INVESTIGATION ALERT: BERNSTEIN LIEBHARD IS INVESTIGATING AMERICAN AIRLINES GROUP INC.

News

do you hold american airlines common stock? if so, please visit amercan airlines group inc. shareholder investigations or contact investor relations manager peter allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

TONIX PHARMACEUTICALS TO PARTICIPATE IN THE NOBLECON20 INVESTOR CONFERENCE

News

chatham, n.j., nov. 26, 2024 (globe newswire) -- tonix pharmaceuticals holding corp. (nasdaq: tnxp) (tonix or the company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, announced today that jessica morris, chief operating officer of tonix pharmaceuticals, will present and conduct investor meetings at noblecon20, noble capital markets' twentieth annual emerging growth equity conference, being held december 3-4 in boca raton, fla.

SRIVARU HOLDING COMPLETES THE INTERIM AUDIT AND ADVANCES PLAN TO COMPLY WITH NASDAQ LISTING STANDARDS

News

grand cayman, cayman islands, nov. 18, 2024 (globe newswire) -- srivaru holding limited (nasdaq: svmh, svmhw) (“srivaru” or the “company”), a manufacturer of premium electric motorcycles, today announced progress in its efforts to gain compliance with nasdaq listing standards. on september 18, 2024, the company received a letter from the office of the general counsel of the nasdaq stock market llc (“nasdaq”) confirming the nasdaq hearing panel's (the “panel”) decision to grant srivaru's request for continued listing on nasdaq. this decision allowed the company additional time to execute its compliance plan (the “plan”), subject to the condition that srivaru demonstrate compliance with certain requirements for continued listing by november 14, 2024. the panel would then evaluate the company's progress and consider its request for additional time to complete the plan.

CAPSTONE PARTNERS RELEASES 2024 MIDDLE MARKET BUSINESS OWNERS RESEARCH SURVEY: CEOS FOCUS ON PERFORMANCE IMPROVEMENT, TURN TO CAPITAL MARKET GROWTH IN HIGH INTEREST RATE ENVIRONMENT

News

boston , nov. 25, 2024 /prnewswire/ -- capstone partners, a leading middle market investment banking firm, released its 2024 middle market business owners survey report, with insights from privately-owned companies across the u.s. this report combines capstone's in-depth middle market knowledge with proprietary data obtained from 404 participating owners of privately-owned, middle market companies. conducted between july 31, 2024, and august 26, 2024, the survey captures sentiment at a pivotal moment in the u.s., identifying ceos' decision making processes, growth, financial, and exit plans, and value drivers that characterized middle market business in 2024.

VCI GLOBAL RECEIVES CONDITIONAL LETTER OF AWARD FOR US$24 MILLION AI CONTRACT

News

kuala lumpur, malaysia, nov. 27, 2024 (globe newswire) -- vci global limited (nasdaq: vcig) (“vci global” or the “company”), through its subsidiary, v-gallant sdn. bhd. (“v-gallant”), is pleased to announce that it has received a conditional letter of award valued at approximately us$24 million from hexatoff group sdn. bhd. (“hexatoff group”) for its proposed data center project in enstek city, malaysia.

WALGREENS BOOTS ALLIANCE PROVIDES NOTICE OF PENDING AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE ACTION

News

deerfield, ill.--(business wire)--walgreens boots (nasdaq:wba): in the united states district court for the district of delaware james clem, derivatively on behalf of walgreens boots alliance, inc.,   plaintiff, v.   james a. skinner, stefano pessina, william c. foote, nancy m. schlichting, ginger l. graham, david j. brailer, janice m. babiak, dominic p. murphy, john a. lederer, josé e. almeida, george r. fairweather, and leonard d. schaeffer,   defendants, -and-   walgreens boots alliance, inc.

FROM NYC TO THE ABCS: JETBLUE BEGINS MORE CARIBBEAN SERVICE WITH FLIGHTS TO BONAIRE

News

new york--(business wire)--jetblue (nasdaq: jblu) today announced the official launch of service between new york's john f. kennedy international airport (jfk) and bonaire's flamingo international airport (bon), with the inaugural flight arriving on the island this afternoon. the twice-weekly roundtrip service, operating on tuesdays and saturdays, is the only nonstop option from new york's jfk to bonaire. with this new addition, jetblue now connects travelers to all three of the abc islands, th.

SOUTHWEST AIRLINES DECLARES 183RD QUARTERLY DIVIDEND

News

dallas , nov. 21, 2024 /prnewswire/ -- southwest airlines co. (nyse: luv) board of directors declared a quarterly cash dividend of $.18 per share to shareholders of record at the close of business on december 26, 2024, on all shares then issued and outstanding. the quarterly dividend will be paid on january 16, 2025.

TEXAS INSTRUMENTS - DIGITAL TRANSFORMATION STRATEGY REPORT 2024: ACCELERATORS, INCUBATORS AND OTHER INNOVATION PROGRAMS

News

dublin, nov. 26, 2024 (globe newswire) -- the "enterprise tech ecosystem series: texas instruments inc. - 2024" company profile has been added to researchandmarkets.com's offering.

WORKDAY ANNOUNCES FISCAL 2025 THIRD QUARTER FINANCIAL RESULTS

News

fiscal third quarter total revenues of $2.160 billion, up 15.8% year over year subscription revenues of $1.959 billion, up 15.8% year over year pleasanton, calif. , nov. 26, 2024 /prnewswire/ -- workday, inc. (nasdaq: wday), a leading provider of solutions to help organizations manage their people and money , today announced results for the fiscal 2025 third quarter ended october 31, 2024.

MERCK TO PARTICIPATE IN THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

News

rahway, n.j.--(business wire)--merck to participate in the citi 2024 global healthcare conference.

PEPSI® AND REGAL ARE TRANSFORMING A NEW YORK CITY THEATRE INTO THE ROMAN COLASSEUM FOR EXCLUSIVE FAN EVENT CELEBRATING PARAMOUNT PICTURES' HIGHLY ANTICIPATED GLADIATOR II FILM

News

fans can sign up to rsvp for the free, immersive activation to get hyped for the upcoming paramount pictures film gladiator ii, only in theatres everywhere on november 22. they'll be transported to "the pepsi colasseum" at regal times square and be the first to experience the movie in 4dx.

EXXONMOBIL TO EXPAND ADVANCED RECYCLING CAPACITY

News

spring, texas--(business wire)--exxonmobil (nyse: xom) plans to invest more than $200 million to expand its advanced recycling operations at its sites in baytown and beaumont, texas. the new operations are expected to start up in 2026 and can help increase advanced recycling rates and divert plastic from landfills. the company plans to build additional units to reach a global recycling capacity of 1 billion pounds per year by 2027. “we are solutions providers, and this multi-million-dollar inve.

FIFTH THIRD BANCORP TO PARTICIPATE IN THE GOLDMAN SACHS U.S. FINANCIAL SERVICES CONFERENCE

News

cincinnati--(business wire)--fifth third bancorp (nasdaq: fitb) will participate in the 2024 goldman sachs u.s. financial services conference on december 11, 2024 at approximately 8:00 am et. tim spence, chairman, chief executive officer and president, and bryan preston, executive vice president and chief financial officer, will represent the company. audio webcast and any presentation slides may be viewed live and for approximately 14 days after the conference through the investor relations se.

SOUTHERN ENERGY CORP. ANNOUNCES THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

News

calgary, ab / accesswire / november 29, 2024 / southern energy corp. ("southern" or the "company") (tsxv:sou)(aim:souc)(otcqx:soutf), an established producer with natural gas and light oil assets in mississippi, announces its third quarter financial and operating results for the three and nine months ended september 30, 2024. selected financial and operational information is outlined below and should be read in conjunction with the company's unaudited consolidated financial statements and related management's discussion and analysis (the "md&a") for the three and nine months ended september 30, 2024, which are available on the company's website at www.southernenergycorp.com and have been filed under the company's profile on sedar+ at www.sedarplus.ca.

DUKE ENERGY FLORIDA'S '12 DAYS OF SAVINGS' OFFERS SCHEDULE OF SUGGESTED ENERGY EFFICIENCY TIPS

News

simple, low-cost to no-cost solutions will help customers save on their electric bills this holiday season st. petersburg, fla.

ARCADIUM LITHIUM RELEASES THIRD QUARTER 2024 RESULTS

News

philadelphia and perth, australia , nov. 7, 2024 /prnewswire/ -- arcadium lithium plc (nyse: altm, asx: ltm, "arcadium lithium" or the "company") today reported results for the third quarter of 2024. as a result of its pending acquisition by rio tinto, announced on october 9, 2024 (the "transaction"), and as is customary during such transactions, arcadium lithium will not hold an earnings conference call in connection with its third quarter financial results.

PALANTIR LAUNCHES AIP FOR DEVELOPERS AT DEVCON

News

denver--(business wire)--palantir technologies inc. (nyse: pltr) held its first developer conference, devcon, november 13th-14th, 2024. this exclusive conference brought together 150 of the most ambitious commercial and government builders and technical leaders for two days of product launches, hands-on development, and competition. this event marked the public launch of new aip for developers features. this launch underscores palantir's commitment to deprecating backend by introducing improved.

DESTINATION XL GROUP, INC. REPORTS THIRD QUARTER FINANCIAL RESULTS

News

sales of $107.5 million, net loss of $(0.03) per diluted share, lowers guidance sales of $107.5 million, net loss of $(0.03) per diluted share, lowers guidance

RIVIAN RECEIVES CONDITIONAL COMMITMENT FOR UP TO $6.6 BILLION LOAN FROM THE U.S. DEPARTMENT OF ENERGY'S ADVANCED TECHNOLOGY VEHICLE MANUFACTURING (ATVM) PROGRAM

News

irvine, calif.--(business wire)--american all-electric automaker rivian automotive (nasdaq: rivn) today announced it has received conditional commitment from the u.s. department of energy's advanced technology vehicle manufacturing (atvm) loan program for a loan of up to $6.6 billion (including $6 billion of principal and approximately $600 million of capitalized interest) to accelerate its growth and leadership of electric vehicle design, development and manufacturing in the united states. if.

BRISTOL MYERS SQUIBB TO PARTICIPATE IN CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE

News

princeton, n.j.--(business wire)--bristol myers squibb to participate in citi's 2024 global healthcare conference.

GILEAD ANNOUNCES NEW ENGLAND JOURNAL OF MEDICINE PUBLICATION OF PURPOSE 2 RESULTS

News

foster city, calif.--(business wire)--gilead sciences, inc. (nasdaq: gild) today announced the new england journal of medicine (nejm) published the full results from the company's pivotal phase 3 purpose 2 trial evaluating twice-yearly lenacapavir for the investigational use of hiv prevention among a broad and geographically diverse range of cisgender men and gender-diverse people. the study found that twice-yearly lenacapavir for pre-exposure prophylaxis (prep) was highly efficacious at reduci.

SNAP INC. ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS

News

santa monica, calif.--(business wire)--snap inc. (nyse: snap) today announced financial results for the quarter ended september 30, 2024. “i'm proud of the team's progress this quarter, delivering strong community growth and deepening engagement while driving improved financial performance,” said evan spiegel, ceo. “our investments in ai and ar are powering new creative experiences for our community and driving innovation across our advertising platform, underpinning our long-term growth opport.

NEW RESEARCH REVEALS CONSUMERS ARE SPENDING SMARTER, NOT LESS THIS HOLIDAY SEASON

News

toronto--(business wire)--affirm (nasdaq: afrm), the payment network that empowers consumers and helps merchants drive growth, today released new research revealing that despite economic uncertainty, canadians are approaching their holiday shopping with strategy, not restraint. the majority (71%) plan to spend the same or more this season, but with a focus on smarter, more deliberate choices. the study, conducted by talker research for affirm, shows that over three in four consumers (77%) are e.

LUCID ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING LUCID GROUP ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

News

new york, nov. 20, 2024 (globe newswire) -- bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, is investigating potential claims against lucid group (nasdaq: lcid) on behalf of long-term stockholders following a class action complaint that was filed against lucid on april 1, 2022 with a class period from november 15, 2021 to august 3, 2022. our investigation concerns whether the board of directors of lucid have breached their fiduciary duties to the company.

DITCHIT DESCENDS ON TIMES SQUARE: A FRESH RIVAL FOR OFFERUP AND FACEBOOK

News

dover, delaware, nov. 22, 2024 (globe newswire) --    ditchit, the innovative local marketplace, has officially arrived in the heart of new york city with a bold and eye-catching advertisement in the iconic times square. this strategic move marks a significant milestone for the company, solidifying its presence in the nation's largest metropolitan area.

THE TJX COMPANIES, INC. REPORTS Q3 FY25 RESULTS; COMP STORE SALES GROWTH OF 3% AT HIGH-END OF PLAN; PRETAX PROFIT MARGIN OF 12.3% AND DILUTED EPS OF $1.14 BOTH WELL ABOVE PLAN; RAISES FY25 PRETAX PROFIT MARGIN AND EPS GUIDANCE

News

framingham, mass.--(business wire)--the tjx companies, inc. (nyse: tjx), the leading off-price apparel and home fashions retailer in the u.s. and worldwide, today announced sales and operating results for the third quarter ended november 2, 2024. net sales for the third quarter of fiscal 2025 were $14.1 billion, an increase of 6% versus the third quarter of fiscal 2024. third quarter fiscal 2025 consolidated comparable store sales increased 3%. net income for the third quarter of fiscal 2025 wa.

ACCENTURE NOMINATES MASAHIKO UOTANI, CHAIRMAN AND CHIEF EXECUTIVE OFFICER OF SHISEIDO, AND JENNIFER NASON, GLOBAL CHAIR, INVESTMENT BANKING OF J.P. MORGAN TO JOIN ITS BOARD OF DIRECTORS

News

new york--(business wire)--accenture announced that its board of directors has nominated masahiko uotani and jennifer nason for election to the board.

TERAWULF ANNOUNCES PROMOTION OF SEAN FARRELL TO CHIEF OPERATING OFFICER

News

farrell to drive operational execution as the company scales data center infrastructure farrell to drive operational execution as the company scales data center infrastructure

VESTIS REPORTS FOURTH QUARTER AND FISCAL 2024 RESULTS

News

atlanta--(business wire)--vestis corporation (nyse: vsts), a leading provider of uniforms and workplace supplies, today announced its results for the fourth quarter and fiscal year ended september 27, 2024. the company also provided its outlook for fiscal year 2025. management commentary “we ended the year with solid fourth quarter results that were in-line with our expectations for revenue and ahead of our expectations for adjusted ebitda,” said kim scott, president and ceo. “as we move into 2.

SLB CAPTURI COMPLETES CONSTRUCTION OF THE WORLD'S FIRST INDUSTRIAL-SCALE CARBON CAPTURE PLANT AT A CEMENT FACILITY

News

oslo, norway--(business wire)--slb capturi has reached a significant milestone of mechanical completion of the carbon capture plant at heidelberg materials' cement facility in brevik, norway. with the full-scale carbon capture plant now complete, including the carbon capture system, compression system, heat integration system, intermediate storage, and loadout facilities, the plant is now ready for testing and commissioning. when operational, this world-first commercial-scale carbon capture pla.

COFFEE BEANS INDUSTRY ANALYSIS AND BUSINESS OPPORTUNITIES, 2024-2032 - SUSTAINABILITY, SPECIALTY COFFEES, AND HOME BREWING TRENDS DRIVE GROWTH, LED BY INDUSTRY GIANTS LIKE STARBUCKS AND LAVAZZA

News

dublin, nov. 05, 2024 (globe newswire) -- the "coffee beans market report and forecast 2024-2032" report has been added to researchandmarkets.com's offering. according to the report, the global coffee beans market reached approximately usd 35.23 billion in 2023. aided by the increased consumer interest in premium and specialty coffees, the market is projected to grow at a cagr of 6.10% between 2024 and 2032, reaching a value of around usd 60.07 billion by 2032. one of the foremost trends aiding the coffee beans market expansion is the growing emphasis on sustainability and ethical sourcing practices. consumers are increasingly aware of the environmental impact and the social conditions under which their coffee is produced. this awareness has driven demand for beans that are certified organic, fair trade, or rainforest alliance certified. these certifications ensure that the coffee is grown without harmful pesticides, herbicides, and that farmers receive fair compensation for their produce. the rise of speciality coffee shops is a crucial coffee beans market trend, which has led to increased consumer interest in premium and speciality coffees. these coffees are often sourced from specific regions and are valued for their unique flavour profiles, which can be influenced by the altitude, climate, and soil conditions of the region where they are grown. the premiumisation trend has encouraged coffee enthusiasts to explore single-origin coffees and limited-edition releases, thereby willing to pay higher prices for high-quality, distinctive products. technological advancements have significantly increased the global coffee beans market value. precision agriculture technology, such as drones and iot sensors, is being used to monitor crop health, optimize water usage, and improve yield quality. on the processing side, innovations in roasting and packaging techniques help preserve the freshness and flavour of the beans for longer periods, enhancing the overall quality of the coffee. the health aspect of coffee consumption has come to the forefront, influencing the global coffee beans market growth. the antioxidant properties of coffee are being highlighted, and products that offer additional health benefits, such as infused coffee beans with vitamins or proteins, are gaining popularity. additionally, the market is seeing a rise in demand for decaffeinated options as consumers seek to enjoy coffee's benefits without the effects of caffeine. the covid-19 pandemic accelerated the shift towards online shopping, and the coffee beans market has not been an exception. e-commerce platforms have become vital for coffee bean sales, offering consumers the convenience of exploring and purchasing a wide variety of beans from around the world from the comfort of their homes. subscription services have also grown, providing regular deliveries of fresh beans based on consumer preferences. with more consumers working from home, there has been a significant uptick in home brewing. enthusiasts are investing in high-quality coffee-making equipment and experimenting with different brewing methods, such as french press, espresso, and cold brew, which require specific types of beans and grinds. this trend has led to increased sales of premium beans and a greater interest in home roasting kits. manufacturers in the global coffee beans market are continuously experimenting with new flavours and blends to capture the attention of a broader audience. this includes the introduction of flavoured beans, such as vanilla, caramel, and hazelnut, and blends that combine beans from various origins to create unique flavour profiles. this trend caters to a segment of the market looking for novelty and variety in their coffee consumption.

SOFI TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCE

News

san francisco--(business wire)--sofi technologies, inc. (nasdaq: sofi), a member-centric, one-stop shop for digital financial services that helps members borrow, save, spend, invest and protect their money, today announced that it will participate in an upcoming investor conference. sofi's cfo, chris lapointe, will participate in a moderated fireside chat discussion at the ubs global technology and ai conference. full session details for the conference appearance are as follows: ubs global tech.

MAXEON ANNOUNCES RESTRUCTURING OF BUSINESS PORTFOLIO

News

maxeon to focus exclusively on u.s. market, executes term sheets with tcl group to address rest-of-world markets singapore , nov. 26, 2024 /prnewswire/ -- maxeon solar technologies (nasdaq: maxn) today announced a broad strategic restructuring of the company's business portfolio and geographic market focus. going forward, the company intends to focus exclusively on the u.s. market where its market presence and planned local manufacturing footprint create a strong platform to drive growth and profitability.

MICROALGO INC. (NASDAQ: MLGO) ANNOUNCED TO JOINTLY ESTABLISH A MICRO-CONSCIOUSNESS QUANTUM RESEARCH CENTER WITH WIMI (NASDAQ: WIMI)

News

beijing , june 4, 2024 /prnewswire/ -- microalgo inc. (nasdaq: mlgo) (the "company" or "microalgo"), today announced that microalgo and wimi will jointly establish a micro-consciousness quantum research center. it will integrate physics, mathematics, medicine, genetics, computer science, biology, polymer chemistry, philosophy, psychology, sociology, and many other disciplines to form a comprehensive research institute based on various disciplines centered on consciousness.

KINDER MORGAN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

News

houston--(business wire)--kmi's board of directors today approved a cash dividend of $0.2875 per share for the third quarter ($1.15 annualized), payable on november 15, 2024.

INDIE SEMICONDUCTOR ANNOUNCES PROPOSED CONVERTIBLE SENIOR NOTES OFFERING

News

aliso viejo, calif.--(business wire)--indie semiconductor, inc. (“indie” or “we”) (nasdaq: indi), an automotive solutions innovator, today announced that it plans to offer, subject to market and other conditions, $175 million aggregate principal amount of its convertible senior notes due 2029 (the “notes”) through a private offering to persons reasonably believed to be qualified institutional buyers in reliance on rule 144a under the securities act of 1933, as amended (the “securities act”). in.

CMG INVESTOR NOTICE: ROBBINS GELLER RUDMAN & DOWD LLP ANNOUNCES THAT CHIPOTLE MEXICAN GRILL, INC. INVESTORS WITH SUBSTANTIAL LOSSES HAVE OPPORTUNITY TO LEAD INVESTOR CLASS ACTION LAWSUIT

News

san diego, dec. 02, 2024 (globe newswire) -- the law firm of robbins geller rudman & dowd llp announces that purchasers or acquirers of chipotle mexican grill, inc. (nyse: cmg) publicly traded common stock and those who purchased chipotle call options or sold put options between february 8, 2024 and october 29, 2024, inclusive (the “class period”), have until friday, january 10, 2025 to seek appointment as lead plaintiff of the chipotle class action lawsuit. captioned stradford v. chipotle mexican grill, inc., no. 24-cv-02459 (c.d. cal.), the chipotle class action lawsuit charges chipotle and certain of chipotle's top current and former executives with violations of the securities exchange act of 1934.

THE SCHALL LAW FIRM ENCOURAGES INVESTOR PARTICIPATION IN AN INQUIRY INTO TRANSOCEAN LTD FOR SECURITIES RELATED INFRACTIONS

News

los angeles, ca / accesswire / november 4, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of transocean ltd. ("transocean" or "the company") (nyse:rig) for violations of the securities laws.

IT'S

News

pittsburgh & chicago--(business wire)--nearly half of americans customize their mac & cheese by adding extra seasonings and ingredients, affectionately known as “mac hacks.”1 today, kraft mac & cheese announces the ultimate mac hack – blending a cult-favorite seasoning and the brand's signature cheese sauce together in a crave-worthy fusion. introducing: kraft mac & cheese everything bagel flavor. the winning submission from kraft's recent “fan flavorites” program, kraft mac & c.

CENTERPOINT ENERGY CONTINUES TO INVEST IN THE SAFETY, RELIABILITY AND RESILIENCY OF ITS NATURAL GAS SYSTEM TO BENEFIT CUSTOMERS

News

the company filed a settlement agreement with the minnesota public utilities commission reached with intervenors on its 2023 rate case minneapolis , nov. 25, 2024 /prnewswire/ -- today, centerpoint energy filed a settlement agreement with the minnesota public utilities commission (commission) for its rate case submitted in november 2023, to adjust natural gas distribution service rates in 2024 and 2025. the company reached a settlement agreement with all intervening parties including: minnesota department of commerce, minnesota office of attorney general – residential utilities division, citizens utility board of minnesota, international union of operating engineers local 49, liuna of minnesota and north dakota, and suburban rate authority.

TERNS PHARMACEUTICALS REPORTS INDUCEMENT GRANT TO NEW EMPLOYEE UNDER NASDAQ LISTING RULE 5635(C)(4)

News

foster city, calif., dec. 02, 2024 (globe newswire) -- terns pharmaceuticals, inc. (“terns” or the “company”) (nasdaq: tern), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that it has granted as of december 1, 2024 an equity inducement award to a new employee under the terms of the 2022 employment inducement award plan, as amended (the “inducement plan”).

MOMENTUS RECEIVES HALO PROTOTYPE ORDER CONTRACT FROM SDA

News

san jose, calif.--(business wire)--momentus inc. (nasdaq: mnts) (“momentus” or the “company”), a u.s. commercial space company that offers satellite buses and technologies, transportation, and other in‑space infrastructure services, today announced that it has been awarded a contract from the u.s. defense department's space development agency (sda) for the hybrid acquisition for proliferated leo (halo) program. sda has been tasked with deploying a constellation of several hundred satellites in.

CHEETAH NET SUPPLY CHAIN SERVICE INC. ANNOUNCES THIRD QUARTER 2024 RESULTS AND PROVIDES CORPORATE UPDATE

News

irvine, calif., nov. 13, 2024 (globe newswire) -- cheetah net supply chain service inc. (“cheetah” or the “company”) (nasdaq cm: ctnt), a provider of warehousing and logistics, today reported results for the quarter ended september 30, 2024 and provided a corporate update.

ASTROTECH REPORTS FIRST QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS

News

austin, texas, nov. 12, 2024 (globe newswire) -- astrotech corporation (nasdaq: astc) (the “company” or “astrotech”) reported its financial results for the first quarter of fiscal year 2025, which ended september 30, 2024.

MURAL ONCOLOGY ANNOUNCES PUBLICATION HIGHLIGHTING PROMISING CLINICAL ANTITUMOR ACTIVITY SHOWN IN ITS ARTISTRY-1 CLINICAL TRIAL OF NEMVALEUKIN, ITS LEAD ENGINEERED FUSION PROTEIN, IN THE JOURNAL FOR IMMUNOTHERAPY OF CANCER

News

nemvaleukin was generally well tolerated in artistry-1, a completed phase 1/2 clinical trial, with durable responses observed in both monotherapy and combination therapy across a range of heavily pretreated advanced solid tumors, including in platinum-resistant ovarian cancer (proc), which does not typically respond to immunotherapies

FUTURE FINTECH ANNOUNCES AN UPDATE OF ITS BLOCKCHAIN DIVISION

News

new york , dec. 2, 2024 /prnewswire/ -- future fintech group inc. (nasdaq: ftft), (hereinafter referred to as "future fintech", "ftft" or the "company"), a comprehensive financial and digital technology service provider, today announced an update of the company's blockchain business division. the division was established in december 2021 to manage its existing blockchain business to include its development as well as the execution of its strategic growth plan.

IVEDA APPLAUDS THE DEPARTMENT OF HOMELAND SECURITY'S NEW AI GUIDELINES

News

mesa, ariz.--(business wire)--iveda® (nasdaq: ivda), a global leader in cloud-based ai technology, commends the u.s. department of homeland security (dhs) for unveiling its groundbreaking roles and responsibilities framework for artificial intelligence in critical infrastructure. as a u.s. department of homeland security safety act (support anti-terrorism by fostering effective technologies act of 2002) designated company since 2009, iveda welcomes this initiative as a significant milestone in.

KAIXIN HOLDINGS EXPLORES STRATEGIC ALTERNATIVES WITH POTENTIAL ACQUISITION IN CRYPTO MINING SECTOR

News

hangzhou, china, nov. 14, 2024 (globe newswire) -- kaixin holdings (“kaixin” or the “company”) (nasdaq: kxin) today announced a major strategic step forward as it explores new growth avenues. in the advanced stages of evaluating strategic alternatives, kaixin is actively considering the acquisition of a controlling equity interest in a leading cryptocurrency mining company based in the middle east. this mining company operates with cost-efficient btc mining machines, optimizing self-mining processes while also offering sophisticated, end-to-end cloud hosting services tailored to meet the growing demand within the crypto mining industry. the facility's long-term, stable energy supply is a critical asset that bolsters operational resilience and cost efficiency, underscoring kaixin's commitment to sustainable and profitable growth.

PASSAGE BIO TO PRESENT AT GUGGENHEIM SECURITIES HEALTHCARE INNOVATION CONFERENCE

News

philadelphia , nov. 06, 2024 (globe newswire) -- passage bio, inc. (nasdaq: pasg), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that will chou, m.d., president and chief executive officer, will present at guggenheim securities healthcare innovation conference on wednesday, november 13, 2024 at 2:30 p.m. et.

SINGULARITY FUTURE TECHNOLOGY ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT

News

great neck, n.y., jan. 30, 2024 (globe newswire) -- singularity future technology ltd. (nasdaq: sgly) (“singularity” or the “company”) today announced a 1-for-10 reverse stock split of its common stock, effective on february 9, 2024. beginning on february 12, 2024, the company's common stock will trade on the nasdaq stock market on a split adjusted basis. trading in the common stock will continue on the nasdaq stock market under the symbol “sgly”. the new cusip number for the common stock following the reverse stock split will be 82935v 307.

REZOLVE AI STRENGTHENS POSITION IN $7.6 BILLION CONVERSATIONAL COMMERCE MARKET (EXPECTED TO REACH $34.41 BILLION BY 2034) FOLLOWING STRATEGIC PARTNERSHIPS WITH MICROSOFT AND GOOGLE

News

new york, nov. 22, 2024 (globe newswire) -- in a remarkable testament to the innovation and impact of rezolve ai's solutions, the company (nasdaq: rzlv), a leader in empathetic conversational ai solutions, has announced back-to-back strategic reseller partnerships with microsoft and google, two of the most prominent leaders in generative ai and cloud technology unlocking unparalleled potential to redefine how businesses engage with customers across the entire consumer journey.

THE CONTAINER STORE ANNOUNCES GLOBAL LICENSING PARTNERSHIP WITH VACANE HOUSEHOLD COMMODITIES CO., LTD.

News

coppell, texas--(business wire)--the container store (nyse: tcs), the nation's leading retailer of organizing solutions, custom spaces, and in-home services, is expanding its customer favorite everything organizer™ collection internationally through a partnership with vacane household commodities, the strategic partner manufacturing this collection. this marks the first licensing of the container store brand internationally. exclusive to the container store, the everything organizer collection.

HYZON ANNOUNCES SUCCESSFUL TRIAL COMPLETION OF NORTH AMERICA'S FIRST FUEL CELL POWERED REFUSE TRUCK WITH MT. DIABLO RESOURCE RECOVERY

News

further demonstrates hydrogen fuel cell technology as a sustainable, zero-emission solution for heavy duty applications bolingbrook, ill. , nov. 14, 2024 /prnewswire/ -- hyzon (nasdaq: hyzn) (hyzon or the company), a u.s.-based, high-performance, hydrogen fuel cell system manufacturer and technology developer focused on providing zero-emission power to decarbonize the most demanding industries, today announced the completion of a successful trial of its refuse collection fuel cell electric truck (fcet) -- developed in partnership with new way trucks -- with mt.

WORKDAY ANNOUNCES FISCAL 2025 THIRD QUARTER FINANCIAL RESULTS

News

fiscal third quarter total revenues of $2.160 billion, up 15.8% year over year subscription revenues of $1.959 billion, up 15.8% year over year pleasanton, calif. , nov. 26, 2024 /prnewswire/ -- workday, inc. (nasdaq: wday), a leading provider of solutions to help organizations manage their people and money , today announced results for the fiscal 2025 third quarter ended october 31, 2024.

COEPTIS THERAPEUTICS ANNOUNCES PHASE 1 DATA ON DVX201 FOR COVID-19 TREATMENT HAS BEEN ACCEPTED FOR PUBLICATION IN MOLECULAR THERAPY METHODS AND CLINICAL DEVELOPMENT

News

study results demonstrate the safety and feasibility of adoptive immunotherapy using allogeneic off-the-shelf nk cells in hospitalized patients with covid at high risk for progression of disease dvx201, the first allogeneic nk cell therapy derived from pooled donor cord blood cd34+ cells, was administered to 9 patients with no dose limiting toxicities, cytokine release syndrome or infusion toxicities wexford, pa. , nov. 7, 2024 /prnewswire/ -- coeptis therapeutics holdings, inc. (nasdaq: coep) (the "company" or "coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced that results from their phase 1 study evaluating dvx201, an allogeneic natural killer (nk) cell therapy, for the treatment of patients hospitalized with covid-19 has been accepted for publication in molecular therapy methods and clinical development.

U-BX TECHNOLOGY LTD. ANNOUNCES EFFECTIVE DATE OF REVERSE STOCK SPLIT

News

new york, nov. 25, 2024 (globe newswire) -- u-bx technology ltd. (the "company" or "u-bx") (nasdaq:ubxg), a leading company providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers, today announced that it has resolved to effect a reverse stock split of the company's ordinary shares and has determined the ratio to be 1-for-16. at the company's annual meeting of shareholders held on october 24, 2024, the company's shareholders approved a reverse stock split and granted the company's board of directors the authority to determine the exact split ratio and on november 2, 2024, the company's board of directors determined the ratio to be 1-for-16. u-bx's ordinary shares will begin trading on an adjusted basis giving effect to the reverse stock split on november 27, 2024 under the existing ticker symbol “ubxg”. the new cusip number of the company's ordinary shares will be g9161k112.

PHOENIX MOTOR INC. ANNOUNCES RECEIPT OF NASDAQ DELISTING NOTICE

News

anaheim, ca / accesswire / november 21, 2024 / phoenix motor inc. (nasdaq:pev) (the "company") today announced that it received a delinquency notification letter from the listing qualifications staff of the nasdaq stock market llc ("nasdaq") due to the company's non-compliance with nasdaq listing rule 5250(c)(1) (the "listing rule") as a result of the company's failure to timely file its quarterly report on form 10-q for the quarterly period ended september 30, 2024 (the "form 10-q"). the listing rule requires listed companies to timely file all required periodic financial reports with the securities and exchange commission (the "sec").

CLPS INCORPORATION APPOINTS MS. SARAH WU AS NON-EXECUTIVE DIRECTOR OF QCC TO DRIVE STRATEGIC GROWTH IN CREDIT CARD SOLUTIONS

News

hong kong , nov. 22, 2024 /prnewswire/ -- clps incorporation (the "company" or "clps") (nasdaq: clps), today announced the appointment of ms. sarah wu as a non-executive director of qinson credit card services limited("qcc"), a wholly-owned subsidiary of clps.

INSPIRATO PARTNERS WITH BLADE URBAN AIR MOBILITY TO ENHANCE MEMBER TRAVEL EXPERIENCES

News

inspirato members to receive exclusive access to blade's premium aviation services inspirato members to receive exclusive access to blade's premium aviation services

AKANDA CORP. ANNOUNCES REVERSE STOCK SPLIT

News

london, united kingdom--(newsfile corp. - november 12, 2024) - akanda corp. (nasdaq: akan) (the "company" or "akanda"), today announced that it expects to implement a 1-for-2 reverse stock split of the company's common shares effective november 14, 2024. the reverse stock split was previously approved by the company's shareholders on march 22, 2024 and board of directors on october 25, 2024 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on november 14, 2024 under the existing ticker symbol "akan".

GAIN THERAPEUTICS PRESENTS PRECLINICAL GT-02287 DATA AT NEUROSCIENCE 2024

News

gt-02287 demonstrates disease modifying capacity in both gba1 and idiopathic parkinson's disease models gt-02287 improves mitochondrial function and provides neuroprotective effect in gba1-parkinson's disease models gt-02287 prevents tau accumulation in a cellular model bethesda, md., oct. 07, 2024 (globe newswire) -- gain therapeutics, inc. (nasdaq: ganx) (“gain”, or the “company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced the presentation of new evidence supporting the disease-modifying activity of gt-02287 in preclinical animal models of both gba-1 and idiopathic parkinson's disease during a late-breaker poster session yesterday at the society for neuroscience (sfn) 2024 conference that is being held october 5-9 in chicago, il.

CAVA TO PARTICIPATE IN MORGAN STANLEY GLOBAL CONSUMER AND RETAIL CONFERENCE

News

washington--(business wire)--cava group, inc. (nyse: cava), the category-defining mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, today announced that it will participate in the morgan stanley global consumer and retail conference on wednesday, december 4, 2024. brett schulman, co-founder and ceo, and tricia tolivar, cfo, will participate in 1x1 meetings and a fireside chat at 10:15 am est. the fireside chat and replay of the event will be available o.

GOLDEN MINERALS CLOSES SALE OF ITS YOQUIVO GOLD-SILVER PROJECT

News

golden, colo.--(business wire)---- $aumn #gold--golden minerals company (“golden minerals”, “golden” or the “company”) (nyse-a: aumn and tsx: aumn) today announced it has closed on the sale of its yoquivo gold-silver project (located in chihuahua state, mexico) (the “yoquivo project”). the buyer is advance metals limited (asx: avm) (“avm”), an asx-listed entity focused on the acquisition, discovery, and advancement of high-quality metals projects. pursuant to the sales agreement that the company announced last.

INTERACTIVE STRENGTH INC. (NASDAQ:TRNR) SUCCESSFULLY CONCLUDES HEARINGS PANEL APPEAL AND CONFIRMS DEMONSTRATED COMPLIANCE LETTER FOR CONTINUED NASDAQ LISTING

News

austin, tx / accesswire / november 27, 2024 / interactive strength inc. (nasdaq:trnr) ("trnr" or "the company"), maker of innovative specialty fitness equipment under the clmbr and forme brands, today announced that the company received a letter confirming demonstrated compliance with listing rule 5550(b)(1) of the nasdaq stock market, which successfully concludes the hearings panel appeal process that began in may. trent ward, co-founder and ceo of trnr, said: "we are excited to receive the confirmation that the company demonstrated compliance with the equity rule and are very appreciative that the hearings panel agreed in august with our potential to regain compliance with the equity rule.

MYSIZE REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

News

highlighting 53% revenue growth and path to profitability   revenues and gross profits up 53% and 61%, respectively, driven by growth at orgad and naiz fit  airport city, israel , aug. 14, 2024 /prnewswire/ -- mysize, inc. (nasdaq: mysz), a leader in ai-driven measurement solutions for the e-commerce industry, today announced its financial results for the second quarter ended june 30, 2024. the company reported robust financial performance, marked by a 53% increase in revenues and a 61% rise in gross profit, reflecting the strong performances of orgad and the successful markets penetration from naiz fit.

VIRPAX ANNOUNCES POSITIVE RESULTS FOR THE SWINE MODEL DOSE RANGE FINDING STUDY FOR PROBUDUR™

News

berwyn, pa.--(business wire)--virpax pharmaceuticals, inc. (nasdaq: vrpx) (“virpax” or the “company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (cns) disorders and anti-viral barrier indications, today announced results from a minipig dose range finding (“drf”) study for probudur. probudur is the company's long-acting liposomal bupivacaine formulation injected at a wound site to provide both immediate.

INHIBIKASE THERAPEUTICS REPORTS THIRD QUARTER FINANCIAL RESULTS AND HIGHLIGHTS RECENT ACTIVITY

News

-- transformative financing worth up to $275 million from top-tier institutional healthcare investors -- -- advancement of ikt-001pro into a late-stage clinical trial program in pulmonary arterial hypertension --

IN8BIO REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS

News

reported 100% of acute myeloid leukemia (aml) patients treated in inb-100 remain in complete remission (cr) at the 2024 european hematology association congress and received fda guidance for a future inb-100 registrational trial inb-100 trial currently expanding enrollment up to approximately 25 patients at the recommended phase 2 dose (rp2d) along with the potential to add additional centers and a prospective parallel observational cohort as a control closed private placement for net proceeds of $11.6 million in october 2024 extending cash runway through 2025 new york, nov. 12, 2024 (globe newswire) --   in8bio, inc . (nasdaq: inab), a leading clinical-stage biopharmaceutical company developing innovative gamma-delta t cell therapies for cancer, today reported financial results for the third quarter ended september 30, 2024, and recent corporate highlights.

AMERICAN SOFTWARE, INC. CHANGES NAME TO LOGILITY SUPPLY CHAIN SOLUTIONS, INC. AND UPDATES NASDAQ TICKER SYMBOL TO LGTY

News

atlanta--(business wire)--american software, inc., a leader in ai-first supply chain planning software, is changing its name to logility supply chain solutions, inc. (logility) to align its name with its brand, which is recognized in the industry and around the world. on october 2, the company's nasdaq ticker symbol will also change from amswa to lgty, aligning with the new name. as part of this evolution, the company's shareholders approved a reclassification of its dual-class share structure.

TRAWS PHARMA PROVIDES BUSINESS UPDATE AND REPORTS Q3 2024 FINANCIAL RESULTS

News

newtown, pa., nov. 14, 2024 (globe newswire) -- traws pharma, inc. (“traws” or “traws pharma”), a clinical stage biopharmaceutical company developing oral small molecules for respiratory viral diseases, today outlined recent business updates and reported unaudited financial results for the third quarter ended september 30, 2024.

DSS, INC. CELEBRATES IMPACT BIOMEDICAL INC.'S SUCCESSFUL IPO AND PROUDLY ADVANCES SHAREHOLDER VALUE

News

new york, sept. 16, 2024 (globe newswire) -- dss, inc. (nyse american: dss), a dedicated supporter and investor in impact biomedical inc. (nyse american: ibo), is delighted to announce the successful pricing of impact biomedical's initial public offering (ipo). impact biomedical, a trailblazer in advancing human healthcare and wellness solutions, has set its ipo price at $3.00 per share, with an initial offering of 1,500,000 shares. trading under the ticker symbol “ibo,” these shares will begin trading on the nyse american market on september 16, 2024.

CROWN HIGHLIGHTS TRUMP ADMINISTRATION POTENTIAL IMPACT ON ITS WATER SOLUTIONS DIVISION

News

-- lead and copper rule improvement (lcri) legislation excluded from u.s. environmental protection agency's (epa) regulatory freeze

SPLASH BEVERAGE GROUP TO HOST CONFERENCE CALL TO DISCUSS 2024 THIRD QUARTER RESULTS & STATE OF THE BUSINESS UPDATE

News

fort lauderdale, fl / accesswire / november 18, 2024 / splash beverage group, inc. (nyse american:sbev) ("splash" or the "company"), a portfolio company of leading beverage brands, announced that it will host a conference call on monday, november 25, 2024 at 8:30 a.m. (et). the c-suite team robert nistico (chairman / ceo), julius ivancsits (cfo), and bill meissner (president / cmo) will be present and will field questions after the formal presentation.

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER STAFFING 360 SOLUTIONS, INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

News

milwaukee--(business wire)--ademi llp is investigating staffing 360 (nasdaq: staf) for possible breaches of fiduciary duty and other violations of law in its transaction with atlantic. click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. there is no cost or obligation to you. in the transaction, the stockholders of staffing 360 will receive only 1.202 atlantic shares for each staffing 360 share. atla.

INHIBRX BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

News

san diego , nov. 14, 2024 /prnewswire/ -- inhibrx biosciences, inc. (nasdaq: inbx) ("inhibrx biosciences" or the "company") today reported financial results for the third quarter of 2024. following the completion of the sale of inbrx-101 by inhibrx, inc. (the "former parent") to sanofi s.a.

CROWN LNG ANNOUNCES EXECUTION OF FINAL AGREEMENTS TO ACQUIRE KAKINADA AND GRANGEMOUTH LNG IMPORT TERMINAL ASSETS

News

london, nov. 01, 2024 (globe newswire) -- crown lng holdings limited (nasdaq: cgbs) (“crown” or “crown lng”), a leading provider of lng liquefaction and regasification terminal technologies for harsh weather locations, today announced the conclusion of two strategic acquisition agreements forming the basis of crown lng's entry into the global lng infrastructure network: kglng and grangemouth. the kglng agreement finalizes the acquisition of all shares of kglng, which owns the operating license for the company's planned lng import terminal in kakinada, india. the grangemouth agreement finalizes the acquisition of lng import terminal assets in grangemouth, scotland from gbtron lands limited.

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER FUSION FUEL GREEN PLC IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

News

milwaukee--(business wire)--ademi llp is investigating fusion fuel (nasdaq: htoo) for possible breaches of fiduciary duty and other violations of law in its transaction with qind. click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. there is no cost or obligation to you. in the transaction, fusion fuel will issue a combination of 19.99% of its ordinary shares, along with convertible preferred shares,.

LOTTERY.COM INC. RECEIVES EXPECTED NOTICE FROM THE NASDAQ STOCK MARKET LLC PERTAINING TO ITS FORM 10-Q OF SEPTEMBER 30, 2024

News

fort worth, texas, nov. 26, 2024 (globe newswire) -- on november 20, 2024, lottery.com inc. (nasdaq: ltry; ltryw) (“lottery.com” or “the company”) received a notice (the “notice”) from the nasdaq stock market llc (“nasdaq”) indicating that, as a result of not having timely filed the form 10-q for the period ended september 30, 2024 with the sec, the company is not in compliance with nasdaq listing rule 5250(c)(1) (the “listing rule”), which requires timely filing of all required periodic financial reports with the sec.

IBOTTA REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

News

grew revenue by 16% year-over-year to $98.6 million and non-gaap revenue by 19%

SPI ENERGY ANNOUNCES RECEIPT OF NASDAQ DELIST DETERMINATION NOTICE

News

mcclellan park, ca / accesswire / november 21, 2024 / spi energy co., ltd., (nasdaq:spi) (the "company"), a global renewable energy company and provider of solar storage solutions for business, residential, government, logistics and utility customers, today announced that it received a letter from the listing qualifications department (the "staff") of the nasdaq stock market llc ("nasdaq") issuing a staff determination (the "staff determination") on november 19, 2024.

AVALO THERAPEUTICS RECEIVES $69.4 MILLION IN PROCEEDS FROM THE FULL EXERCISE OF PRIVATE PLACEMENT WARRANTS

News

wayne, pa. and rockville, md., nov. 12, 2024 (globe newswire) -- avalo therapeutics, inc. (nasdaq: avtx), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced that it has received $69.4 million in gross proceeds from the full exercise of the warrants issued in a march 2024 private placement.

AUSTIN GOLD PROVIDES UPDATE ON EXPLORATION ACTIVITIES

News

summary - austin has completed a large soil and stream sediment sampling program at its lone mountain project near the carlin gold district in elko county, nevada. results will be reported once all samples have been received and analyzed.

EVOGENE REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

News

conference call and webcast: today, november 21, 2024, 9:00 am et financial highlights: in the first nine months of 2024, total revenues reached approximately $6.9 million, compared to approximately $5.1 million in the first nine months of 2023. in q3 2024, total revenues reached approximately $1.8 million, compared to approximately $3.8 million in q3 2023.

ROSS STORES REPORTS THIRD QUARTER EARNINGS, UPDATES FOURTH QUARTER GUIDANCE

News

dublin, calif.--(business wire)--ross stores, inc. (nasdaq: rost) today reported earnings per share for the 13 weeks ended november 2, 2024 of $1.48, up from $1.33 per share for the 13 weeks ended october 28, 2023. net income for the period rose to $489 million versus $447 million last year. sales for the 2024 third quarter were $5.1 billion, up from $4.9 billion in the prior year, with a comparable store sales gain of 1%. for the nine months ended november 2, 2024, earnings per share were $4.5.

REVELATION BIOSCIENCES INC. ANNOUNCES FDA ACCEPTANCE OF GEMINI IND

News

san diego--(business wire)---- $revb #aki--revelation biosciences, inc. (nasdaq: revb) (the “company” or “revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of disease, announced today that the united states food and drug administration (fda) has accepted its investigational new drug (ind) application for gemini. this game changing milestone allows the company to initiate its us based phase 1b clinical study to evaluate the potent.

WETOUCH TECHNOLOGIES INC. ANNOUNCES $15 MILLION STOCK BUYBACK PROGRAM

News

chengdu, china , july 8, 2024 /prnewswire/ -- wetouch technologies inc. (nasdaq: weth) ("wetouch" or the "company"), a leading innovator in the global touch display industry, today announced a stock buyback program to repurchase up to $ 15 million of the company's common stock. under the program, the company is authorized to repurchase its shares from time to time in the open market or in privately negotiated transactions.

ROMA GREEN FINANCE LIMITED RECEIVES NASDAQ DEFICIENCY NOTICE REGARDING MINIMUM BID PRICE REQUIREMENT

News

ordinary shares will continue to trade on the nasdaq capital market, and the company's listing on such exchange is not affected by the receipt of the notice

FENBO HOLDINGS LIMITED ANNOUNCES FISCAL YEAR 2024 FIRST HALF FINANCIAL RESULTS

News

hong kong, oct. 03, 2024 (globe newswire) -- fenbo holdings limited (nasdaq: febo) (the “company”, “we”, “our”, “us” or “febo”), an established original equipment manufacturer (oem) for a global home essential company, producing electrical hair styling products under the “remington” brand which are sold to overseas markets, today announced its unaudited financial results for the six months ended june 30, 2024.

CLEARPOINT NEURO ANNOUNCES FDA DE NOVO MARKETING AUTHORIZATION OF SMARTFLOW CANNULA FOR DIRECT DELIVERY OF GENE THERAPY TO THE BRAIN

News

only device approved to deliver first disease-modifying treatment for aadc deficiency in the united states solana beach, ca / accesswire / november 13, 2024 / clearpoint neuro, inc. (nasdaq:clpt) (the "company"), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the u.s. food and drug administration (fda) has granted marketing authorization for the smartflow neuro cannula using the de novo pathway. the smartflow neuro cannula is intended for intraputaminal administration of ptc therapeutics' gene therapy kebilidi™ (eladocagene exuparvovec-tneq) for the treatment of aromatic l-amino acid decarboxylase (aadc) deficiency.

FACING INCREASED COSTS, 64% OF MEDICARE BENEFICIARIES EXPRESS HIGHER CONFIDENCE IN THE FUTURE OF MEDICARE UNDER A TRUMP ADMINISTRATION

News

ehealth research examines costs & trends midway through medicare's annual enrollment period and outlines beneficiaries' priorities for president-elect trump austin, texas , nov. 19, 2024 /prnewswire/ -- new original research from ehealth, inc. (nasdaq: ehth), a leading online private health insurance marketplace, finds that the average premium for medicare part d drug plans selected by beneficiaries in the first half of medicare's annual enrollment period is up 17% from a year ago. survey data included in ehealth's report show that 64% of medicare beneficiaries are more confident in the future sustainability of medicare based on the outcome of the presidential election.

NEW FINDINGS SHOW MOLECULIN'S ANNAMYCIN OVERCOMES RESISTANCE TO VENETOCLAX IN AML

News

preclinical data accepted for online publication at ash annual meeting reveal significant activity of annamycin in venetoclax resistant aml model new preliminary clinical results show annamycin plus ara-c achieved 60% cr/cri in subjects who were relapsed from or refractory to venetoclax regimens; more than 4 times greater than published historical rates annamycin demonstrates an even greater potential than previously reported to address a significant aml patient population for which treatment options are extremely limited new data from mb-106 trial show median overall survival of 11.6 months in subjects receiving annarac as 2nd line therapy houston , nov. 18, 2024 /prnewswire/ -- moleculin biotech, inc., (nasdaq: mbrx) ("moleculin" or the "company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced new findings supporting the ability of annamycin to overcome resistance to venetoclax in acute myeloid leukemia ("aml").  this includes data from preclinical in vitro studies recently accepted for online publication at the upcoming american society of hematology ("ash") annual meeting, and correlates with efficacy demonstrated by recent preliminary clinical data in subjects who were relapsed from or refractory to first line venetoclax regimens and were then treated with annamycin in combination with ara-c ("annarac").

GRINDR TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

News

los angeles--(business wire)--grindr inc. (nyse: grnd), the global gayborhood in your pocket™, today announced participation in the following upcoming investor events. citi's 2024 global tmt conference location: new york, ny date: thursday, september 5, 2024 fireside chat presentation: 4:40 pm et speaker: chief financial officer, vanna krantz goldman sachs communacopia + technology conference location: san francisco, ca date: tuesday, september 10, 2024 fireside chat presentation: 4:25 pm pt sp.

GORILLA TECHNOLOGY GROUP ADDS TECH LUMINARY THOMAS SENNHAUSER TO BOARD OF DIRECTORS

News

london, united kingdom--(newsfile corp. - december 2, 2024) - gorilla technology group inc. (nasdaq: grrr) ("gorilla" or the "company"), proudly announces the appointment of thomas sennhauser to its esteemed board of directors, effective 1st december 2024. with a stellar career spanning over two decades, thomas brings unparalleled expertise in technology leadership, r&d and digital transformation.

INOTIV RANKED NUMBER 138 FASTEST-GROWING COMPANY IN NORTH AMERICA ON THE 2024 DELOITTE TECHNOLOGY FAST 500™

News

acquiring and developing services and resources to build a full service, customer-focused cro has fueled 847% revenue growth acquiring and developing services and resources to build a full service, customer-focused cro has fueled 847% revenue growth

LUCID DIAGNOSTICS SUBMITS CLINICAL EVIDENCE PACKAGE TO MOLDX SEEKING MEDICARE COVERAGE FOR ESOGUARD® ESOPHAGEAL DNA TEST

News

new york , nov. 20, 2024 /prnewswire/ -- lucid diagnostics inc.  (nasdaq: lucd) ("lucid" or the "company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of pavmed inc. (nasdaq: pavm), today announced that it has submitted its complete clinical evidence package for its esoguard® esophageal dna test in support of a request for reconsideration of local coverage determination (lcd) l39256 "moldx: molecular testing for detection of upper gastrointestinal metaplasia, dysplasia, and neoplasia" to molecular diagnostics program (moldx), administered by palmetto gba, a medicare administrative contractor (mac) for the centers for medicare & medicaid services (cms), to seek coverage for esoguard. "this submission is the culmination of many years of persistent hard work by our team and our many clinical research partners, and represents perhaps the most important milestone in lucid's history," said lishan aklog, m.d.

908 DEVICES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND UPDATES 2024 REVENUE OUTLOOK

News

boston--(business wire)--908 devices inc. (nasdaq: mass), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today reported financial results for the quarter ended september 30, 2024. “while we are pleased that our revenue increased year-over-year due to our newly acquired products, our third quarter results fell short of our expectations due to challenges from the delayed fy24 federal budget, delays with advancing international contracts, and ongoing softness in the.

PERASO TO PARTICIPATE AT THE BENCHMARK COMPANY'S DISCOVERY ONE-ON-ONE INVESTOR CONFERENCE ON DECEMBER 11

News

san jose, capellen / accesswire / november 26, 2024 / peraso inc. (nasdaq:prso), ("peraso" or the "company"), a pioneer in mmwave wireless technology solutions, today announced the company will participate at the benchmark company's 13th annual discovery investor conference to be held wednesday, december 11, 2024, at the new york athletic club in new york city. ron glibbery, ceo, and jim sullivan, cfo, are scheduled to host one-on-one meetings with analysts and investors throughout the day.

INNOVATIVE EYEWEAR LAUNCHES FOUR NEW LUCYD LYTE SMART GLASSES WITH ENHANCED FEATURES

News

new smart eyewear is the company's first to use advanced tr90 plastic for improved adjustability and durability. miami , nov. 25, 2024 /prnewswire/ -- innovative eyewear, inc. (nasdaq: lucy; lucyw), the developer of chatgpt-enabled smart eyewear under the lucyd®, nautica®, eddie bauer® and reebok® brands, announced today that it has officially launched the lucyd lyte 2024 edition, bringing several improvements to the company's core product line.

HUADI INTERNATIONAL GROUP CO., LTD. ANNOUNCES FISCAL YEAR 2023 FINANCIAL RESULTS

News

beijing , feb. 6, 2024 /prnewswire/ -- huadi international group co., ltd. ("hudi" or the "company") (nasdaq: hudi), a leading developer and manufacturer of industrial stainless steel seamless pipes and tubes products in china, today announced its financial results for the fiscal year ended september 30, 2023.

WESTCON-COMSTOR TAPS TTEC DIGITAL TO LEAD GLOBAL SALES PROCESS OPTIMIZATION

News

denver , dec. 2, 2024 /prnewswire/ -- ttec holdings inc. (nasdaq: ttec), a leading global cx (customer experience) technology and services innovator for ai-enabled cx with solutions from ttec engage and ttec digital, today announced that ttec digital has completed the first phases of a successful global sales process optimization program with westcon-comstor, a global technology provider and specialist distributor. westcon-comstor operates across emea and apac, connecting the world's leading it vendors with a channel of technology resellers, systems integrators and service providers.

WAVE LIFE SCIENCES TO PRESENT AT JEFFERIES LONDON HEALTHCARE CONFERENCE

News

cambridge, mass., nov. 15, 2024 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage biotechnology company focused on unlocking the broad potential of rna medicines to transform human health, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the jefferies london healthcare conference on wednesday, november 20, 2024, at 4:30 p.m. gmt / 11:30 a.m. et.

RELAY THERAPEUTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

News

reported interim rly-2608 data demonstrating 9.2-month median pfs in heavily pre-treated patients with pi3kα-mutated, hr+/her2- metastatic breast cancer at rp2d

ELEVAI LABS INC. ANNOUNCES REVERSE STOCK SPLIT TO MAINTAIN NASDAQ LISTING COMPLIANCE

News

newport beach, calif., nov. 22, 2024 (globe newswire) -- elevai labs inc. (nasdaq: elab) (elevai" or the "company") announced today it will implement a 1-for-200 reverse stock split (“reverse stock split”) of its common stock, which will be effective at midnight on november 27, 2024.

VINCERX REPORTS POSITIVE INITIAL CLINICAL DATA FROM ONGOING VIP943 PHASE 1 DOSE-ESCALATION STUDY AND PROVIDES PIPELINE AND CORPORATE UPDATES

News

vip943 demonstrates promising safety and tolerability and achieves two complete responses to date in phase 1 dose-escalation study, reinforcing the program's potential and validating the versaptx™ platform technology

TAYLOR DEVICES ANNOUNCES FIRST QUARTER RESULTS

News

north tonawanda, n.y. , sept. 27, 2024 /prnewswire/ -- taylor devices, inc. (nasdaq smallcap: "tayd") announced today that it had first quarter sales of $11,617,856, up from last year's first quarter sales of $9,923,628.

VROOM ANNOUNCES THIRD QUARTER 2024 RESULTS

News

new york--(business wire)--vroom, inc. (nasdaq:vrm) today announced financial results for the third quarter ended september 30, 2024. highlights of third quarter 2024 $51.1 million cash and cash equivalents as of september 30, 2024 $32.9 million of liquidity available to uacc under the warehouse credit facilities $(37.7) million net loss from continuing operations $(25.5) million adjusted ebitda1 entered into an agreement to restructure $290 million of unsecured convertible notes, into equity t.

URBAN ONE, INC. REPORTS THIRD QUARTER 2024 RESULTS

News

silver spring, md. , nov. 12, 2024 /prnewswire/ -- urban one, inc. (nasdaq: uonek) (nasdaq: uone) today reported its results for the quarter ended september 30, 2024.

ORGANOVO PRESENTS CLINICAL DATA OF FXR314 IN PHASE 2 MASH IN AN ORAL PRESENTATION AT THE LIVER MEETING

News

san diego, nov. 20, 2024 (globe newswire) -- organovo holdings, inc. (nasdaq:onvo), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (ibd) including ulcerative colitis, today announces that its oral presentation of its lead clinical stage drug fxr314 by dr. eric lawitz of the texas liver institute and the university of texas health san antonio was featured at the liver meeting, sponsored by the american association for the study of liver diseases (aasld). the meeting was held november 15-19, 2024 in san diego, california.

INNOVIZ REPORTS THIRD QUARTER 2024 RESULTS

News

entered two new oem programs through agreement with level 4 platform partner with expected sop in 2026; met operational target of 2-3 additional customer programs in 2024 and exceeded midpoint of revenue guidance of q3 with $4.5 million in revenue q3 cash used in operations and capital expenditures of $17.7 million compared to $28.6 million in q3 2023 and $21.6 million in q2 2024 tel aviv, israel , nov. 13, 2024 /prnewswire/ -- innoviz technologies ltd. (nasdaq: invz) (the "company" or "innoviz"), a leading tier-1 direct supplier of high-performance, automotive grade lidar sensors and perception software, today provided commercial and strategic updates on its business, reported its financial results for the quarter ended september 30, 2024, provided guidance for full year 2024, and reiterated its full year nre target.

A2Z CUST2MATE SOLUTIONS CORP. TO PARTICIPATE IN 13TH ANNUAL ROTH TECHNOLOGY CONFERENCE NOVEMBER 19-20, 2024

News

tel aviv, israel / accesswire / november 7, 2024 / a2z cust2mate solutions corp. ("a2z" or the "company") (nasdaq:az)(fra - wkn: a3csq), a global leader in innovative technology solutions, today announced that gadi graus, ceo will participate in the 13th annual roth technology conference being held november 19 - 20, 2024, at the hard rock hotel in new york city. a2z's management will conduct one-on-one meetings on both days.

PETMEDS MIGRATES TO ORDERGROOVE AS ITS NEW SUBSCRIPTION AND MEMBERSHIP TECHNOLOGY PARTNER

News

new york--(business wire)--ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with petmed express, inc. (nasdaq: pets), the original online pet pharmacy dedicated to supporting the health and well-being of four-legged family members. this collaboration marks a significant step in modernizing and scaling petmeds + petcarerx's (pets) subscription and membership capabilities to maximize operational efficiency.

FREYR BATTERY REPORTS THIRD QUARTER 2024 RESULTS

News

new york & oslo, norway & newnan, ga.--(business wire)--freyr battery, inc. (nyse: frey) (“freyr” or the “company”), a developer of sustainable clean energy capacity and solutions, today reported financial results for the third quarter of 2024. results overview, financing, and liquidity freyr reported a net loss attributable to stockholders for the third quarter of 2024 of $(27.5) million, or $(0.20) per diluted share compared to a net loss for the third quarter of 2023 of $(9.8) million or $(0.

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF TRAVERE THERAPEUTICS, INC. - TVTX

News

new york, ny / accesswire / november 27, 2024 / pomerantz llp is investigating claims on behalf of investors of travere therapeutics, inc. ("travere" or the "company") (nasdaq:tvtx). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.

ORIC® PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

News

south san francisco and san diego, nov. 25, 2024 (globe newswire) -- oric pharmaceuticals, inc. (nasdaq: oric), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in december:

JIADE LIMITED RECEIVES NASDAQ NOTIFICATION LETTER REGARDING MINIMUM BID PRICE DEFICIENCY

News

chengdu, china, aug. 02, 2024 (globe newswire) -- jiade limited (nasdaq: jdzg) (the “company”), a company that specializes in providing one-stop comprehensive education supporting services to adult education institutions, today announced that the company received a letter (the “notification letter”) from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) on july 31, 2024, notifying the company that it is not in compliance with the minimum bid price requirement set forth in the nasdaq listing rules for continued listing on the nasdaq.

XTI AEROSPACE PROVIDES THIRD QUARTER 2024 BUSINESS UPDATE

News

englewood, colo. , nov. 14, 2024 /prnewswire/ -- xti aerospace, inc. (nasdaq: xtia) ("xti aerospace" or the "company") today provided a business update and announced the scheduled filing of its quarterly report on form 10-q for the quarter ended september 30, 2024.

VYNE THERAPEUTICS ANNOUNCES POSITIVE PHASE 1A SAD DATA FOR VYN202, A NOVEL BD2-SELECTIVE BET INHIBITOR

News

bridgewater, n.j., sept. 12, 2024 (globe newswire) -- vyne therapeutics inc. (nasdaq: vyne) (“vyne” or the “company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need, today announced positive data from the single ascending dose (“sad”) portion of its ongoing phase 1a trial of vyn202. the phase 1a trial is a two-part, double-blind, placebo-controlled dose-escalation study in healthy volunteers consisting of sad and multiple ascending dose (“mad”) components to evaluate the safety, tolerability, pharmacokinetics (“pk”) and pharmacodynamics of vyn202. findings from the sad portion of the phase 1a trial to date are as follows:

SAFE & GREEN HOLDINGS CORP. PROVIDES THIRD QUARTER 2024 BUSINESS UPDATE

News

miami, fl, nov. 27, 2024 (globe newswire) -- safe & green holdings corp. (nasdaq: sgbx) (“safe & green holdings” or the “company”), a leading developer, designer, and fabricator of modular structures, today provided a third quarter business update, highlighting recent operational achievements and strengthened financial positioning.

SANDFIRE RESOURCES AMERICA ANNOUNCES VARIATION TO BRIDGE LOAN AGREEMENT

News

white sulphur springs, mont., nov. 21, 2024 (globe newswire) -- sandfire resources america inc. ("sandfire america" or the "company") announces that it has entered into a fourth variation agreement (the "fourth variation") to its bridge loan agreement, as amended (the “bridge loan”) with sandfire bc holdings (australia) pty ltd. ("sandfire bc"), the company's largest shareholder, and tintina montana inc., a wholly-owned subsidiary of the company ("tintina montana").

CUTERA® ANNOUNCES PARTNERSHIP WITH THE ADAPTIVE TRAINING FOUNDATION

News

brisbane, calif.--(business wire)--cutera, inc. (nasdaq: cutr), a leading provider of aesthetic and dermatology solutions, announces their partnership with the adaptive training foundation (atf), a non-profit organization that provides access and inclusion to individuals living with physical or traumatic impairments empowering them through exercise and community. the cutera team, with the support of edward alvarez, dds, c.ac, owner of madison avenue face and body, has provided atf participants.

ISPECIMEN NAMED TOP COMPETITOR IN $4.4 BILLION USD MARKET

News

biospecimen market to exceed $13.5 billion usd by 2032 woburn, massachusetts--(newsfile corp. - november 8, 2024) - ispecimen inc. (nasdaq: ispc) ("ispecimen" or the "company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the addressable biospecimen contract research services market is attractive and growing. in fact, according to aceinsight analytic, the market is presently valued at usd 4.4 billion as of 2023 and is predicted to reach usd 13.5 billion by the year 2032, growing at a 13.3% cagr during the forecast period.

NEW PEER-REVIEWED PUBLICATION VALIDATES NEXALIN'S DEEP INTRACRANIAL FREQUENCY STIMULATION (DIFS) TECHNOLOGY, REINFORCING LEADERSHIP IN HIGH-GROWTH NEUROMODULATION MARKET

News

report highlights nexalin's unique non-invasive solution addressing deep brain dysfunction, positioned to revolutionize mental health treatment report highlights nexalin's unique non-invasive solution addressing deep brain dysfunction, positioned to revolutionize mental health treatment

NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN

News

nutex health continues to expand its national footprint with its third hospital opening in 2024 houston , nov. 18, 2024 /prnewswire/ -- nutex health inc. ("nutex health" or the "company") (nasdaq: nutx), a physician-led, integrated healthcare delivery system comprised of 23 state-of-the-art micro hospitals and hospital outpatient departments (hopds) in ten states and primary care-centric, risk-bearing physician networks, today announced the opening of milwaukee er & hospital, located at 1751 w layton ave, milwaukee, wi 53221. the staff of medical experts at milwaukee er & hospital are bringing the community 24/7/365 days of concierge-level care.

'ART ATTACK! THE DISSECTION OF TERRIFIER 3' - NEW BEHIND-THE-SCENES FILM FROM THE PRODUCERS OF 'PENNYWISE: THE STORY OF IT' - COMING SOON TO CINEVERSE'S SCREAMBOX

News

explore the blood-soaked creation of one of horror's most iconic villains with exclusive cast and crew interviews los angeles , nov. 26, 2024 /prnewswire/ -- cineverse corp.  (nasdaq: cnvs), an innovative streaming technology and entertainment company, today announced art attack! the dissection of terrifier 3, a behind-the-scenes film that gives fans an exclusive look into the making of terrifier 3, in theaters now.

BILL TO OFFER $1.0 BILLION OF CONVERTIBLE SENIOR NOTES DUE 2030

News

san jose, calif.--(business wire)--bill holdings, inc. (nyse: bill) (“bill”) today announced that it proposes to offer $1.0 billion aggregate principal amount of convertible senior notes due 2030 (the “notes”), subject to market conditions and other factors. the notes are to be offered and sold in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “act”). bill also intends to grant the i.

BIOXCEL THERAPEUTICS ANNOUNCES PRICING OF $7.0 MILLION PUBLIC OFFERING

News

new haven, conn., nov. 22, 2024 (globe newswire) -- bioxcel therapeutics, inc. (the “company”) (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share (“common stock”), and accompanying warrants to purchase up to 5,600,000 shares of common stock, and, in lieu thereof to certain investors that so choose, pre-funded warrants to purchase up to 9,000,000 shares of common stock and accompanying warrants to purchase up to 9,000,000 shares of common stock, at a combined public offering price of $0.48 per share and accompanying warrant (or $0.479 per share underlying each pre-funded warrant and accompanying warrant, which equals the public offering price per share of common stock and accompanying warrant less the $0.001 exercise price per share of the pre-funded warrants). gross proceeds to the company from the offering are expected to be approximately $7.0 million, before deducting underwriting discounts and commissions and offering expenses, and excluding the exercise of any of the warrants.

PROKIDNEY TO PARTICIPATE IN TWO UPCOMING CONFERENCES: EVERCORE HEALTHCONX CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE

News

winston-salem, n.c., nov. 26, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (ckd), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in december:

METAGENOMI, INC. CLASS ACTION: LEVI & KORSINSKY REMINDS METAGENOMI INVESTORS OF THE PENDING CLASS ACTION LAWSUIT WITH A LEAD PLAINTIFF DEADLINE OF NOVEMBER 25, 2024 - MGX

News

new york, ny / accesswire / november 25, 2024 / if you suffered a loss on your metagenomi, inc. (nasdaq:mgx) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/metagenomi-lawsuit-submission-form?prid=113560&wire=1 or contact joseph e. levi, esq.

NEKTAR THERAPEUTICS PRESENTS FIRST PRECLINICAL DATA FROM NOVEL CSF-1 PROGRAM, NKTR-422, AT 2024 AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CONVERGENCE

News

- nktr-422 demonstrated inflammation resolution and tissue repair in multiple preclinical models of chronic inflammatory conditions - san francisco , nov. 18, 2024 /prnewswire/ -- nektar therapeutics (nasdaq: nktr) today announced its oral presentation highlighting preclinical data on nktr-422 at the 2024 american college of rheumatology (acr) conference, being held in washington, d.c. from november 14-19, 2024.

GAXOS LABS ADDS SUNO AI AND ELEVANLABS TO GIVE GAME DEVELOPERS SPEECH, SOUND, AND MUSIC CAPABILITIES THROUGH ARTIFICIAL INTELLIGENCE

News

roseland, nj, nov. 21, 2024 (globe newswire) -- gaxos.ai inc. ("gaxos" or the "company"), a company developing artificial intelligence applications across various sectors, today announced that the company successfully integrated suno ai and elevenlabs into their artificial intelligence solution for game developers and publishers, gaxos labs.

ACTELIS NETWORKS RECEIVES TWO EXPANSION ORDERS FOR WASHINGTON DC DEPARTMENT OF TRANSPORTATION IN COLLABORATION WITH MULTI-BILLION DOLLAR PARTNER M.C. DEAN

News

actelis today announced that it has received new orders for the washington dc dot, following the approximately $2.3 million order announced in may 2024.

PRECIGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND BUSINESS UPDATES

News

–   completed pre-bla meeting with fda with full alignment on content of bla, including cmc module, and path for fourth quarter 2024 rolling bla submission for prgn-2012 †  in rrp under accelerated approval pathway – –   commercial and manufacturing readiness campaign underway for prgn-2012 in anticipation of a potential 2025 launch – –   confirmatory clinical trial for prgn-2012 in rrp was initiated in accordance with guidance from fda to initiate prior to submission of the bla; continuing enrollment – –   preparing for end of phase 1b meeting with fda in early 2025 for prgn-3006 in aml – –   presented preclinical data at sitc 2024 for prgn-3008, a next generation ultracar-t targeting cd19 showcasing potential to be best-in-class cd19-targeting car-t treatment in oncology and autoimmunity – germantown, md. , nov. 14, 2024 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced third quarter 2024 financial results and business updates.

ABSCI REPORTS BUSINESS UPDATES AND THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

News

successfully delivered ai de novo designed antibody sequences to astrazeneca, fulfilling first milestone under collaboration

EZGO ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED MARCH 31, 2024

News

changzhou, china , sept. 9, 2024 /prnewswire/ -- ezgo technologies ltd.

QUANTUM-SI HIGHLIGHTS MAJOR TECHNICAL ADVANCES, NEXT-GENERATION PLATFORM ARCHITECTURE AND NEW PROTEOMIC APPLICATIONS AT INVESTOR & ANALYST EVENT

News

branford, conn.--(business wire)--quantum-si incorporated (nasdaq: qsi) (“quantum-si,” “qsi” or the “company”), the protein sequencing company™, today announced the highlights of an investor & analyst event that was hosted in new york city on november 20th, 2024. quantum-si's management team announced platinum™ pro, the company's evolution of platinum, as well as proteus™, the company's new cutting-edge proteomics platform of the future, that is now under development. “we are very excited t.

TELOMIR PHARMACEUTICALS CONFIRMS AGE REVERSAL, INCREASED LONGEVITY AND IMPROVED HEALTHSPAN IN GROUNDBREAKING PRECLINICAL STUDY WITH TELOMIR-1

News

miami, fl / accesswire / november 21, 2024 / telomir pharmaceuticals, inc. (nasdaq:telo) ("telomir" or the "company"), an emerging leader in age-reversal science, today announced groundbreaking preclinical results confirming the efficacy of telomir-1, a compound designed to effectively turn back the biological clock and support longevity. using advanced in vivo microfluidic technology, in collaboration with nagi biosciences sa, the study demonstrates significant age-reversal effects in aging model organisms treated with telomir-1, effectively turning back the biological clock.

ROCKET LAB SIGNS $23.9M CHIPS INCENTIVES AWARD TO BOOST SEMICONDUCTOR MANUFACTURING

News

long beach, calif.--(business wire)---- $rklb--rocket lab signs $23.9m chips incentives award to boost semiconductor manufacturing.

ART'S WAY MANUFACTURING REPORTS PROGRESS DESPITE DIFFICULT MARKET CONDITIONS IN THIRD QUARTER OF FISCAL 2024; CEO TRANSITION

News

armstrong, ia / accesswire / october 4, 2024 / art's way manufacturing co., inc. (nasdaq:artw) (the "company"), a diversified manufacturer and distributor of equipment serving agricultural and research needs, announces its financial results for the third quarter of fiscal 2024 and nine months ended august 31, 2024. the company also reports that it has reached a mutual separation agreement with president and ceo david king effective october 1, 2024.

NINE MILE METALS ANNOUNCES COMPLETION OF PRIVATE PLACEMENT FINANCING

News

vancouver, british columbia--(newsfile corp. - november 15, 2024) - nine mile metals ltd. (cse: nine) (otc pink: vmsxf) (fse: kq9) (the "company" or "nine mile") is issuing the following press release to provide an update to its press release dated september 3, 2024, (click here) and to announce the closing of its private placement to raise $53,332 (the "private placement") through the issuance of an aggregate of 1,066,640 units (each a "unit") at a price of $0.05 per unit.

BENEFICIENT REPORTS RESULTS FOR FIRST QUARTER FISCAL 2025

News

maintained cost-efficient operating profile new machine-automated pricing system enhances portfolio growth capabilities in support of multibillion dollar liquidity and primary capital product launch dallas, aug. 14, 2024 (globe newswire) -- beneficient (nasdaq: benf) (“ben” or the “company”), a technology-enabled financial services holding company that provides liquidity and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2025 first quarter, which ended june 30, 2024. commenting on the fiscal 2025 first quarter results, beneficient management said: “our financial results improved on a sequential basis resulting in our first profitable quarter as a public company.

RED ROBIN'S SPICY NEW MENU ITEMS WILL SET TASTEBUDS ABLAZE THIS FALL

News

guests get a free glass of 'scorpion antidote' to combat the sting for a limited time englewood, colo. , sept. 10, 2024 /prnewswire/ --  red robin gourmet burgers (nasdaq: rrgb) has introduced a hot new lineup of menu items featuring this year's hottest food trend – spicy and swicy (sweet and spicy) – including a new gourmet burger with waves of heat, three new wing sauces, plus hand-crafted premium cocktails and shareable desserts!

GDC ANNOUNCES SYNCWAVEX: REDEFINING VIDEO PRODUCTION WITH DIRECT AUDIO-TO-VIDEO AI TECHNOLOGY

News

new york, aug. 23, 2024 (globe newswire) -- gd culture group limited (“gdc” or the “company”) (nasdaq: gdc), and its subsidiary, ai catalysis corp. (“ai catalysis”), today announced the launch of syncwavex on august 22, 2024, a groundbreaking web-based ai application under its software brand ai box. syncwavex is set to revolutionize the way videos are created by automatically syncing lip and facial movements with audio, enabling ultra-realistic videos with unmatched ease. the launch of syncwavex highlights the company's dedication to ai-driven innovation and empowers creators and influencers to thrive in the digital realm.

PUBLICSQUARE REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

News

west palm beach, fla.--(business wire)--psq holdings, inc. (nyse: psqh) (“publicsquare,” or the “company”), america's leading commerce and payments ecosystem valuing life, family, and liberty, today announced financial results for the second quarter 2024. michael seifert, chairman and chief executive officer of publicsquare, commented, “our second-quarter results show we are on a solid path towards profitability with revenue growth far outpacing the growth of expenses, but the greatest success.

JIUZI HOLDINGS INC. ANNOUNCES 1-FOR-13 REVERSE SHARE SPLIT

News

hangzhou, china, june 28, 2024 (globe newswire) -- jiuzi holdings, inc. (nasdaq: jzxn; the "company"), a leading new energy vehicle (nev) dealership group under the brand name "jiuzi" in china, today announced that it will effect a reverse share split of its outstanding ordinary shares, par value $0.00015 per share (the “ordinary shares”), at a ratio of 1-for-13, to be effective on or around the open of trading on july 3, 2024.

HERAMBA ELECTRIC SIGNS $26 MILLION E-MOBILITY CONTRACT WITH SEATTLE, WASHINGTON AREA

News

has signed $75 million in year-to-date north american orders, following recent contract win announcement with chicago transit authority düsseldorf, germany and atlanta , aug. 27, 2024 /prnewswire/ -- heramba electric plc (nasdaq: pita) ("heramba electric" or the "company"), a global technology company focused on decarbonization of public and commercial transportation, announced that its wholly-owned subsidiary kiepe electric ("kiepe") has been awarded a $26 million battery upgrade program by king county metro in seattle, washington for enhanced in motion charging (imc®) on its electric trolley buses. the three-year agreement will ensure enhanced in-motion charging capability for electric trolley buses and provide king county with upgraded battery packs that will deliver approximately three times the capacity of the original energy storage system (ess).

KINETA REOPENS ENROLLMENT FOR THE VISTA-101 CLINICAL TRIAL EVALUATING KVA12123 IN PATIENTS WITH ADVANCED SOLID TUMOR CANCER

News

effective immediately, clinical sites in the vista-101 phase 1/ phase 2 clinical trial can resume screening of patients for enrollment in the clinical study

AIR INDUSTRIES GROUP AND ALL-SYSTEM AEROSPACE INTERNATIONAL EXECUTE MARKETING AGREEMENT TO PURSUE FOREIGN MILITARY SALES

News

bay shore, n.y.--(business wire)---- $airi--air industries group (“air industries”) (nyse american: airi), a leading manufacturer of precision components and assemblies for large aerospace and defense prime contractors, today announced a partnership with all-system aerospace international (“all-system aerospace”), to expand access in the rapidly growing foreign military sales (“fms”) market. the partnership agreement covers sales to 17 countries across europe, the middle east, asia, and the pacific, mark.

ALTAMIRA THERAPEUTICS TO PRESENT AT H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 9-11

News

hamilton, bermuda, sept. 03, 2024 (globe newswire) -- altamira therapeutics ltd. ("altamira" or the "company") (nasdaq: cyto), a company dedicated to developing and commercializing rna delivery technology for targets beyond the liver, today announced that its founder, chairman, and ceo thomas meyer will be presenting at the h.c. wainwright 26th annual global investment conference, being held virtually and in person on september 9-11, 2024, at lotte new york palace hotel in new york city.

HEARTCORE TO PRESENT AT THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 11, 2024

News

new york and tokyo, aug. 28, 2024 (globe newswire) -- heartcore enterprises, inc. (nasdaq: htcr) (“heartcore” or the “company”), a leading enterprise software and data consulting services company based in tokyo, will be presenting and holding one-on-one meetings at the h.c. wainwright 26th annual global investment conference on september 9-11, 2024 at the lotte new york palace hotel in new york city.

ALLIANCE ENTERTAINMENT TO HOST FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS CONFERENCE CALL ON SEPTEMBER 19 AT 4:30 P.M. EASTERN TIME

News

plantation, fla., sept. 05, 2024 (globe newswire) -- alliance entertainment holding corporation (nasdaq: aent), a global distributor and wholesaler specializing in music, movies, video games, electronics, arcades, toys, and collectibles, will hold a conference call on thursday, september 19, 2024, at 4:30 p.m. eastern time to discuss its results for the fourth quarter and fiscal year ended june 30, 2024. a press release detailing these results will be issued prior to the call.

THE SAUDI FOOD AND DRUG AUTHORITY (SFDA) APPROVES BIOMERICA'S AT HOME PSA SCREENING TEST TO DETECT EARLY SIGNS OF PROSTATE CANCER

News

- 10-minute at-home psa test for early detection of prostate cancer - first order already shipped to saudi arabia - prostate cancer is the second most common cancer in men globally irvine, calif., sept. 04, 2024 (globe newswire) -- biomerica, inc. (nasdaq: bmra) is pleased to announce that the saudi food and drug authority (sfda) has approved the company's fortel® prostate (psa) screening test to be sold and used in the country.

CLEARMIND MEDICINE ANNOUNCES PUBLICATION OF INTERNATIONAL PATENT APPLICATION FOR INNOVATIVE MDMA-BASED COMBINATION TREATMENT

News

pioneering therapeutic approach aims to enhance safety and efficacy in mental health and addiction treatments

APPLIED DNA SELECTED BY LRQA FOR ISOTOPIC TESTING PILOT PROJECT IN PAKISTAN

News

- pilot project to demonstrate effectiveness of certaint® for cotton textile traceability - stony brook, ny / accesswire / september 4, 2024 / applied dna sciences, inc. (nasdaq:apdn) (applied dna), a leader in pcr-based dna technologies, today announced the receipt of a subcontract award from lrqa following a competitive tender for a pilot isotopic testing program. under the terms of the subcontract, applied dna, together with its traceability partner, isotech (a stratum reservoir company), will employ certaint® to conduct isotopic testing and analysis to support cotton traceability in pakistan.

LIPELLA PHARMACEUTICALS TO PARTICIPATE AT H.C. WAINWRIGHT'S 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE IN NEW YORK

News

company has two lead drug candidates for rare disease indications in ind approved phase 2 clinical trials using the 505(b)(2) pathway pittsburgh, pa, august 27, 2024 – lipella pharmaceuticals, inc. (nasdaq: lipo) (“lipella”) will participate at h.c.

N2OFF INC. SOLAR PV JV SECURES APPROVAL TO CONNECT FIRST PV SOLAR PROJECT IN GERMANY TO THE POWER GRID OF A REGIONAL ENERGY PROVIDER

News

according to solter r a this approval demonstrates the project meets the required safety standards to connect to the power grid and is currently aligned with the set timeline and milestones

SMART FOR LIFE TO ATTEND THE NEWTOPIA NOW 2024 CONFERENCE IN COLORADO

News

company representatives to explore collaboration opportunities at the launch of the industry's latest premier health & wellness event company representatives to explore collaboration opportunities at the launch of the industry's latest premier health & wellness event

SOLIDION TECHNOLOGY, INC. ANNOUNCES PRICING OF $4 MILLION PRIVATE PLACEMENT

News

dallas, texas, aug. 30, 2024 (globe newswire) -- solidion technology, inc., (the “company,” "solidion,” “we,” “our” or “us”), an advanced battery technology solutions provider, today announced that it has entered into a securities purchase agreement with institutional investors to raise approximately $4 million in aggregate cash proceeds, before deducting fees to the placement agent and other offering expenses payable by the company. the closing of the private placement is expected to occur on september 3, 2024, subject to the satisfaction of certain customary closing conditions set forth in the securities purchase agreement.

1847 REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

achieves approximately 4% sequential increase in revenue for q2 2024 compared to q1 2024 gross profit was $6.7m in q2 2024 compared to $5.9m in q2 2023, a 14.2% year-over-year increase new york, ny / accesswire / august 19, 2024 / 1847 holdings llc ("1847" or the "company") (nyse american:efsh), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today provided a business update and reported financial results for the second quarter ended june 30, 2024. mr. ellery w.

NCL CORPORATION LTD. ANNOUNCES PRICING OF $315,000,000 OF SENIOR NOTES

News

miami, sept. 03, 2024 (globe newswire) -- ncl corporation ltd. (“nclc”), a subsidiary of norwegian cruise line holdings ltd. (nyse: nclh), announced today that it has priced $315.0 million aggregate principal amount of its 6.250% senior notes due 2030 (the “notes”), which were offered in a private offering (the “notes offering”) that is exempt from the registration requirements of the securities act of 1933, as amended (the “securities act”).

VOCODIA RECEIVES DELISTING NOTICE FROM CBOE AND PLANS OTCQB LISTING IN THE NEAR-TERM

News

boca raton, fl, september 10, 2024, vocodia holdings corp. (the “company”), a pioneering ai software company specializing in practical ai solutions, today announced that it has received a delisting notification from cboe bzx exchange, inc.

PHARMA TWO B AND HEPION PHARMACEUTICALS, INC. ANNOUNCE FILING OF REGISTRATION STATEMENT ON FORM F-4 RELATED TO PROPOSED MERGER

News

kiryat ono, israel and edison, n.j., sept. 04, 2024 (globe newswire) -- pharma two b ltd. (“pharma two b”), a late-clinical stage company that is developing p2b001, an innovative combination product candidate for the treatment of parkinson's disease (“pd”) and hepion pharmaceuticals, inc. (nasdaq: hepa) (“hepion”), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“nash”), hepatocellular carcinoma (“hcc”), and other chronic liver diseases, today jointly announced the filing of a registration statement of pharma two b on form f-4 (the "registration statement") with the u.s. securities and exchange commission (the “sec”).

OFS CAPITAL CORPORATION ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS

News

chicago--(business wire)--ofs capital corporation (nasdaq: ofs) (“ofs capital,” the “company,” “we,” “us,” or “our”) today announced its financial results for the fiscal quarter ended june 30, 2024. second quarter financial highlights net investment income decreased to $0.26 per common share for the quarter ended june 30, 2024 from $0.42 per common share for the quarter ended march 31, 2024. net gain on investments of $0.51 per common share for the quarter ended june 30, 2024, primarily compris.

ATLASCLEAR HOLDINGS LAUNCHES NEW ONLINE ACCOUNT APPLICATION WITH PACSQUARE

News

tampa, fla.--(business wire)--atlasclear holdings, inc. (“atlasclear holdings”) (nyse american: atch) today announced the launch, in collaboration with pacsquare technologies llc (“pacsquare”), of a next-generation online account application that it expects will streamline the onboarding process for its clients in the u.s. “we are thrilled to announce the launch of our automated online account application, designed to simplify and enhance the onboarding process for clients eager to trade in the.

CASTOR MARITIME INC. REPORTS NET INCOME OF $22.9 MILLION FOR THE THREE MONTHS ENDED JUNE 30, 2024 AND NET INCOME OF $45.2 MILLION FOR THE SIX MONTHS ENDED JUNE 30, 2024

News

limassol, cyprus, aug. 08, 2024 (globe newswire) -- castor maritime inc. (nasdaq: ctrm) (“castor” or the “company”), a diversified global shipping company, today announced its results for the three months and six months ended june 30, 2024.

ONCOCYTE'S VITAGRAFT™ KIDNEY USED TO MONITOR EFFECT OF DARATUMUMAB ON ANTI-BODY MEDIATED REJECTION IN NEW CASE SERIES STUDY

News

case series represents second study showing vitagraft kidney as a measure of response to the benefit of therapy for one leading cause of allograft failure irvine, calif., august 12, 2024 — oncocyte corp.

MOBIX LABS ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS

News

irvine, calif.--(business wire)--mobix labs, inc. (nasdaq: mobx) (“mobix labs”, “mobix” or the “company”), a leader in advanced connectivity solutions, today announced financial results for its fiscal third quarter ended june 30, 2024. “we are pleased with the june quarter's results, closing the acquisition of rage systems and our growing pipeline of synergistic m&a opportunities for extending our tech portfolio and end markets,” said fabian battaglia, ceo of mobix labs. “quickly increasing.

COSMOS HEALTH REGAINS FULL COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS

News

chicago, il / accesswire / august 23, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that the company has regained compliance with listing rule 5250(c)(1) (the "filing rule"), in connection with the filing of its 2023 annual report on form 10-k (the "annual report") and its financial results for the first quarter ended march 31, 2024, on form 10-q (the "first quarter report"). on april 17 and may 21, 2024, the company received notification letters (the "notification letters") from the listing qualifications department of the nasdaq stock market ("nasdaq") stating that it no longer met the periodic filing requirement for the nasdaq stock market filing rule.

DERMATA THERAPEUTICS ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 9-11, 2024

News

san diego, ca / accesswire / september 5, 2024 / dermata therapeutics, inc. (nasdaq:drma; drmaw) ("dermata" or the "company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced it will be presenting at the h.c. wainwright 26th annual global investment conference, being held september 9-11, 2024.

SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER CYCLO THERAPEUTICS, INC. HAS OBTAINED A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

News

milwaukee , aug. 23, 2024 /prnewswire/ -- ademi llp is investigating cyclo therapeutics (nasdaq: cyth) for possible breaches of fiduciary duty and other violations of law in its transaction with rafael holdings. click here to learn how to join our investigation https://www.ademilaw.com/case/cyclo-therapeutics-inc or call guri ademi toll-free at 866-264-3995.

SHENZHEN TOMORROW INNOVATION CORE TECHNOLOGY CO., LTD. ACQUIRED GUJI TECHNOLOGY, STRENGTHENING AI STRATEGIC LAYOUT

News

shenzhen, china, aug. 29, 2024 (globe newswire) -- shenzhen tomorrow innovation core technology co., ltd. (“shenzhen tomorrow innovation”), a wholly owned subsidiary of top kingwin ltd. (“top kingwin”) (nasdaq - tcjh), announces the successful acquisition of guji technology (shenzhen) co., ltd. (“guji technology”), marking a significant step in shenzhen tomorrow innovation's ai industry strategy.

OXBRIDGE RE REPORTS UPDATE ON BUSINESS AND SECOND QUARTER 2024 RESULTS

News

grand cayman, cayman islands, aug. 08, 2024 (globe newswire) -- oxbridge re holdings limited (nasdaq: oxbr ), (the “company”), together with its subsidiaries which is engaged in the business of tokenized real-world assets (“rwas”) initially in the form of tokenized reinsurance securities, and reinsurance solutions to property and casualty insurers in the gulf coast region of the united states, reported its results for the three and six months ended june 30, 2024.

PRESIDIO PROPERTY TRUST, INC. ANNOUNCES EARNINGS FOR THE SECOND QUARTER ENDED JUNE 30, 2024

News

san diego, ca / accesswire / august 14, 2024 / presidio property trust, inc. (nasdaq:sqft)(nasdaq:sqftp)(nasdaq:sqftw) (the "company"), an internally managed, diversified real estate investment trust ("reit"), today reported earnings for its quarter ended june 30, 2024. "during the first and second quarters, we entered into 10 leases with new tenants totaling nearly 36,000 sf.

BROADWAY FINANCIAL CORPORATION ANNOUNCES RESULTS FOR FIRST QUARTER 2024

News

los angeles--(business wire)--broadway financial corp. q1 2024 earnings release.

LUCID DIAGNOSTICS TO HOST SYMPOSIUM ON NON-ENDOSCOPIC ESOPHAGEAL PRECANCER SCREENING AT THE 20TH INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS (ISDE) WORLD CONGRESS

News

leading experts to discuss advances in technologies to prevent esophageal cancer through esophageal precancer screening new york , sept. 10, 2024 /prnewswire/ -- lucid diagnostics inc.  (nasdaq: lucd) ("lucid" or the "company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of pavmed inc. (nasdaq: pavm), announced that it will be participating as the sole diamond sponsor at the 20th international society for diseases of the esophagus (isde) world congress being held from september 22-24, 2024, at the edinburgh international convention centre in edinburgh, scotland.

SIMPPLE LTD PROVIDES UPDATE ON NEW LEADERSHIP INITIATIVES AND PROGRESS

News

singapore, aug. 05, 2024 (globe newswire) -- simpple ltd provides update on new leadership initiatives and progress

SI-BONE TO PRESENT AT MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE ON SEPTEMBER 4, 2024

News

santa clara, calif., aug. 22, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming morgan stanley 22nd annual global healthcare conference in new york. management will be hosting a fireside chat on wednesday, september 4, 2024, at 10:45 a.m. eastern time / 7:45 a.m. pacific time.

SAFE AND GREEN DEVELOPMENT CORPORATION TO DEVELOP AN ECO FRIENDLY RETAIL OUTLET ON 18-ACRE PROPERTY THROUGH JOINT VENTURE

News

miami , sept. 4, 2024 /prnewswire/ -- safe and green development corporation (nasdaq: sgd) ("sg devco or the "company"), a leading real estate and technology development company, today announced a new joint venture with properties by milk & honey llc ("milk & honey"), a texas-based real estate development firm.

HALLADOR ENERGY COMPANY REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS

News

- q2 total revenue of $90.9 million - - q2 net loss of $10.2 million or $(0.27) earnings per share - - q2 operating cash flow of $23.5 million - - q2 adjusted ebitda loss of $(5.8) million -

MULTISENSOR AI TO ATTEND THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE

News

houston, tx / accesswire / august 27, 2024 / multisensor ai holdings, inc. (nasdaq:msai), a pioneer in ai-powered industrial condition-based maintenance and process control solutions, announced today that it will be attending the h.c. wainwright 26th annual global investment conference on september 9-11, 2024, at the lotte new york palace hotel in new york city.

UNIVEST SECURITIES, LLC ANNOUNCES CLOSING OF $3.46 MILLION REGISTERED DIRECT OFFERING FOR ITS CLIENT QUALIGEN THERAPEUTICS, INC. (NASDAQ: QLGN)

News

new york, sept. 06, 2024 (globe newswire) -- univest securities, llc (“univest”), a member of finra and sipc, and a full-service investment bank and securities broker-dealer firm based in new york, today announced the closing of registered direct offering (the “offering”) of (i) 14,724,058 shares of common stock priced at $0.130 per share, with pre-funded warrants exercisable for 11,972,754 shares with respect to the registered direct offering for its client qualigen therapeutics, inc. (nasdaq: qlgn) (the “company”), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer.

NETCAPITAL TO PRESENT AT H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE

News

boston, ma, sept. 06, 2024 (globe newswire) -- netcapital inc. (nasdaq: ncpl, ncplw) (the “company”), a digital private capital markets ecosystem, announced today that martin kay, ceo, will present virtually at the h.c. wainwright 26th annual global investment conference being held in new york, ny, from september 9 – 11th, 2024.

CONTEXT THERAPEUTICS APPOINTS DR. KAREN SMITH AND DR. LUKE WALKER TO BOARD OF DIRECTORS

News

the appointments of dr. karen smith and dr. luke walker to the board bring extensive operational and clinical development experience to support corporate and pipeline strategy the appointments of dr. karen smith and dr. luke walker to the board bring extensive operational and clinical development experience to support corporate and pipeline strategy

HEALTHCARE TRIANGLE BREAKS NEW GROUND IN AI-POWERED PATIENT DATA MANAGEMENT WITH READABL.AI

News

pleasanton, calif., april 03, 2024 (globe newswire) -- healthcare triangle, inc. (nasdaq: hcti) (“healthcare triangle,” “hcti” or the “company”), in a pioneering move, a leading health system has partnered with healthcare triangle to utilize a groundbreaking cloud-based ai and machine learning solution. this collaboration establishes a revolutionary benchmark in the management and utilization of patient data, ultimately elevating the standards for enhanced care delivery.

BINAH CAPITAL GROUP, INC. ANNOUNCES RECEIPT OF NASDAQ NON-COMPLIANCE NOTICE

News

new york , may 24, 2024 /prnewswire/ -- binah capital group, inc. (the "company") today announced that it received a notice (the "notice") from the listing qualifications department of the nasdaq stock market llc ("nasdaq") notifying the company that due to the company's failure to timely file its quarterly report on form 10-q for the fiscal quarter ended march 31, 2024 (the "form 10-q"), with the securities and exchange commission (the "sec"), the company is not in compliance with nasdaq's continued listing requirements under nasdaq listing rule 5250(c)(1) (the "rule"), which requires the timely filing of all required periodic reports with the sec. the notice states that the company has until july 21, 2024, to submit to nasdaq a plan to regain compliance with the nasdaq listing rules.

SPORTSMAN'S WAREHOUSE HOLDINGS, INC. ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS

News

west jordan, utah, sept. 03, 2024 (globe newswire) -- sportsman's warehouse holdings, inc. (“sportsman's warehouse” or the “company”) (nasdaq: spwh) today announced financial results for the thirteen weeks ended august 3, 2024.

NEUROSENSE THERAPEUTICS ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID PRICE NOTIFICATION

News

cambridge, mass. , aug. 30, 2024 /prnewswire/ -- neurosense therapeutics ltd.

UL SOLUTIONS WARNS OF POTENTIALLY HAZARDOUS COMMUNICATIONS CABLE

News

northbrook, ill.--(business wire)--the following is a notification from ul solutions that the communications cable that bears the serial numbers identified below may pose a potential fire hazard. the communications cable does not comply with the appropriate safety standards. name of product: cat 5e 350mhz cmr model number w-cat5e/ccu/1000/w unshielded twisted pair 24 awg/4pair/1000ft remedy: ul solutions recommends that this product be removed from service. identification on the cable: e468535.

VISLINK TO DEBUT DRAGONFLY V AND INCAM-GV TRANSMITTERS AT IBC 2024

News

the company will showcase its market-leading solutions for elevating live production mt. olive, new jersey, sept.

CHANSON INTERNATIONAL HOLDING ANNOUNCES FISCAL YEAR 2023 FINANCIAL RESULTS

News

urumqi, china , april 30, 2024 /prnewswire/ -- chanson international holding (nasdaq: chsn) (the "company" or "chanson"), a provider of bakery, seasonal, and beverage products through its chain stores in china and the united states, today announced its financial results for the fiscal year ended december 31, 2023. mr. gang li, chairman of the board of directors and chief executive officer of the company, commented, "in 2023, we witnessed growing demand, driven by positive consumer sentiment.

FOXO TECHNOLOGIES SUBSIDIARY, MYRTLE RECOVERY CENTERS, RECEIVES TWO FULL LICENSES FROM THE TENNESSEE DEPARTMENT OF MENTAL HEALTH AND SUBSTANCE ABUSE SERVICES

News

minneapolis, mn, aug. 08, 2024 (globe newswire) -- foxo technologies inc. (nyse american: foxo) (the “company”), today announced that its recently acquired subsidiary, myrtle recovery centers, inc. (“myrtle”), has been granted two full licenses from the tennessee department of mental health and substance abuse services, effective august 1, 2024, for 12 months. the first license authorizes the provision of services for alcohol and drug residential detoxification treatment, as well as alcohol and drug residential rehabilitation treatment. the second license authorizes the provision of services for non-residential office-based opiate treatment.

SINGING MACHINE TO ANNOUNCE ITS FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2024

News

fort lauderdale, fl, aug. 14, 2024 (globe newswire) -- the singing machine company, inc. (“singing machine” or the “company”) (nasdaq: mics) -- the worldwide leader in consumer karaoke products -- today announced that its earnings for its second quarter of 2024 will be released monday, august 19, 2024. the same day management will host a conference call at 4:00 pm eastern time to discuss the financial results and provide a business update. management will also provide an update on the acquisition integration of semicab, an emerging ai-powered technology provider serving the global logistics space.

NEXTCURE TO PRESENT AT THE H.C. WAINWRIGHT 5TH ANNUAL NEURO PERSPECTIVES VIRTUAL CONFERENCE

News

beltsville, md., june 20, 2024 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies, today announced that it will present and host institutional investor meetings at the h.c. wainwright 5th annual neuro perspectives virtual conference on thursday, june 27, 2024.

JAZZ PHARMACEUTICALS TO PRESENT ADVANCEMENTS IN SOLID TUMOR ONCOLOGY RESEARCH AT ESMO 2024

News

new and updated data from an ongoing phase 2 trial of zanidatamab, an investigational dual her2-targeted bispecific antibody, in combination with chemotherapy for first-line treatment of her2-positive metastatic gastroesophageal adenocarcinoma (mgea) dublin , sept. 9, 2024 /prnewswire/ -- jazz pharmaceuticals plc (nasdaq: jazz) today announced that the company, along with its partners, will present five abstracts at the european society for medical oncology (esmo) congress 2024 from september 13-17, 2024, in barcelona, spain.

ABOVE FOOD STRENGTHENS ITS PET FOOD INGREDIENT PLATFORM WITH RECENT MONTANA-BASED ASSET ACQUISITION

News

acquisition expands above food's pet food business to approximately us$110m of combined company revenues on a proforma basis

SRM ANNOUNCES CUSTOM DESIGNED PRODUCT ORDER FOR IN-(MOVIE)THEATER MARKETPLACE

News

jupiter, fl, june 10, 2024 (globe newswire) -- srm entertainment, inc. , (nasdaq: srm) (the “company” or “srm”) is pleased to announce a new order for srm custom designed, nostalgic movie character key chains which will be available online and in shops at one of the world's largest movie theater chain. the intial order will help theaters promote the enhanced merchandising experience which allows movie goers to purchase memorabilla, souveniers and gifts in theater.

GENPREX COLLABORATORS TO PRESENT POSITIVE PRECLINICAL DATA ON THE USE OF REQORSA® GENE THERAPY AT THE 2024 EORTC-NCI-AACR SYMPOSIUM ON MOLECULAR TARGETS AND CANCER THERAPEUTICS

News

poster presentations to focus on reqorsa as a potential treatment for ras inhibitor resistant lung cancer, mesothelioma and glioblastoma austin, texas , sept. 9, 2024 /prnewswire/ -- genprex, inc. ("genprex" or the "company") (nasdaq: gnpx ), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its research collaborators were selected to present at the upcoming 2024 eortc-nci-aacr symposium on molecular targets and cancer therapeutics being held october 23-25, 2024 in barcelona, spain.

HALL OF FAME RESORT & ENTERTAINMENT COMPANY TO PARTICIPATE IN UPCOMING CONFERENCES

News

canton, ohio , sept. 9, 2024 /prnewswire/ -- hall of fame resort & entertainment company (nasdaq: hofv, hofvw) (the "company"), the only resort, entertainment and media company centered around the power of professional football, announced that it will be participating at the upcoming investor conferences.

SONNET BIOTHERAPEUTICS TO PARTICIPATE IN THE VIRTUAL INVESTOR CLOSING BELL SERIES

News

princeton, n.j., sept. 04, 2024 (globe newswire) -- sonnet biotherapeutics holdings, inc. (the “company” or “sonnet”) (nasdaq: sonn), a clinical-stage company developing targeted immunotherapeutic drugs, today announced that it will participate in the virtual investor closing bell series on monday, september 9, 2024, at 4:00 pm et.

CHINA PHARMA HOLDINGS, INC. EXPECTS TO LAUNCH ITS DRY EYE DISEASE THERAPEUTIC DEVICE IN THE FIRST QUARTER OF 2025

News

haikou, china , aug. 19, 2024 /prnewswire/ -- china pharma holdings, inc. (nyse american: cphi) ("china pharma", or the "company"), an nyse american-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in china, today announced that through hainan helpson medical and biotechnology co., ltd. ("helpson"), our wholly owned subsidiary, it expects to launch its dry eye disease therapeutic device in the first quarter of 2025 in china.

ROSEN, TOP RANKED GLOBAL COUNSEL, ENCOURAGES ZOOMINFO TECHNOLOGIES, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION – ZI

News

new york, sept. 10, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of class a common stock of zoominfo technologies, inc. (nasdaq: zi) between november 10, 2020 and august 5, 2024, both dates inclusive (the “class period”). a class action lawsuit has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than november 4, 2024.

TIZIANA LIFE SCIENCES APPOINTS NEW CHIEF EXECUTIVE OFFICER

News

new york, aug. 19, 2024 (globe newswire) -- tiziana life sciences, ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-cd3 monoclonal antibody, today announced the appointment of ivor elrifi as its chief executive officer (ceo), effective immediately.

ALTISOURCE ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS

News

luxembourg, july 25, 2024 (globe newswire) -- altisource portfolio solutions s.a. (“altisource” or the “company”) (nasdaq: asps), a leading provider and marketplace for the real estate and mortgage industries, today reported financial results for the second quarter 2024.

AINOS SECURES TAIWAN INVENTION PATENT AND ADVANCES GLOBAL PATENT PROTECTION FOR VELDONA, A BREAKTHROUGH IN CORONAVIRUS TREATMENT AND PREVENTION

News

this patent marks a major leap in ainos' antiviral research, contributing to global efforts against coronavirus infections san diego, ca / accesswire / september 3, 2024 / ainos, inc. (nasdaq:aimd)(nasdaq:aimdw) ("ainos" or the "company"), an innovative healthcare company focused on advanced ai-driven point-of-care testing (poct) and low-dose interferon therapeutics, is pleased to announce that its groundbreaking veldona® formulation has been granted an invention patent in taiwan and has filed for global patent protection under the patent cooperation treaty (pct). this patent represents a significant milestone in the treatment and prevention of coronavirus infections.

MAPLE LEAF FOODS ANNOUNCES INCOMING CHIEF FINANCIAL OFFICER OF THE PORK COMPLEX

News

mississauga, on , aug. 15, 2024 /prnewswire/ - maple leaf foods inc. (the "company") (tsx: mfi) today announced that deepak bhandari has been named as chief financial officer for the company's pork business, which is set to be spun off as an independent, publicly traded company in 2025. with a breadth of food industry and financial experience, bhandari rejoins the maple leaf foods organization where he had a career spanning 13 years in progressively senior roles within the company's finance organization.

STONEGATE CAPITAL PARTNERS UPDATES COVERAGE ON BIO-PATH HOLDINGS, INC. (BPTH) Q2 24

News

dallas, texas--(newsfile corp. - september 4, 2024) - bio-path holdings, inc. (nasdaq: bpth): stonegate capital partners updates coverage on bio-path holdings, inc. (nasdaq: bpth) for q2 2024. to view the full announcement, including downloadable images, bios, and more, click here.

GOODRX REPORTS SECOND QUARTER 2024 RESULTS

News

santa monica, calif.--(business wire)--goodrx holdings, inc. (nasdaq: gdrx) ("we," "us," "our," “goodrx,” or the “company”), the leading prescription savings platform in the u.s., has released its financial results for the second quarter of 2024. second quarter 2024 highlights revenue1 and adjusted revenue1 of $200.6 million net income of $6.7 million; net income margin of 3.3% adjusted net income1 of $32.4 million; adjusted net income margin1 of 16.1% adjusted ebitda1 of $65.4 million; adjuste.

BLOOMZ ANNOUNCES BUSINESS ALLIANCE WITH SONILUDE INC. TO JOINTLY PRODUCE ORIGINAL ANIMATION PROJECTS

News

tokyo, japan / accesswire / september 10, 2024 / bloomz inc. ("bloomz" or the "company"), a japanese audio production and voice actor management company, announced today that on september 9, 2024, it entered into a business alliance agreement with sonilude inc. ("sonilude"), a japanese animation sound production company, to jointly plan and produce original animation projects. sonilude has successfully produced sound works for numerous popular animation projects, including bella, trigun stampede, kaiju no.

CONTEXTLOGIC INC. REPORTS SECOND-QUARTER FINANCIAL RESULTS

News

oakland, calif., aug. 08, 2024 (globe newswire) -- contextlogic inc. (nasdaq: logc), (“contextlogic,” the “company,” “we” or “our”) today reported its financial results for the quarter and six months ended june 30, 2024.

SEELOS THERAPEUTICS ANNOUNCES PRICING OF $1.1 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES

News

new york , may 16, 2024 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel) ("seelos" or the "company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("cns") disorders and rare diseases, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 380,968 shares of common stock and pre-funded warrants to purchase up to 81,239 shares of common stock at a price of $2.46 per share (or $2.459 per pre-funded warrant) in a registered direct offering priced at-the-market under nasdaq rules, resulting in total gross proceeds of approximately $1.1 million, before deducting the placement agent's fees and other estimated offering expenses. the company also agreed to issue to the investors unregistered warrants to purchase up to 924,414 shares of common stock in a concurrent private placement.

ECD AUTO DESIGN ANNOUNCES COLLABORATION WITH ROUSH FOR CUSTOM CLASSIC MUSTANG BUILDS

News

kissimmee, fla., sept. 10, 2024 (globe newswire) --  ecd automotive design, inc. (nasdaq:ecda) (“ecda” or the “company”), an industry leader in delivering restored, modified and electrified land rover defenders, jaguars, and other classic and collectible automobiles announces its new collaboration with roush, a premier provider of high-performance engines and automotive products. this strategic collaboration will bring roush's renowned engineering excellence to ecd auto design's recently announced custom classic mustang builds, offering clients unparalleled performance and craftsmanship.

PARAZERO SIGNS AN AGREEMENT WITH AUTONOMOUS SOLAR PANELS DRONE COMPANY VALUED OVER $200,000

News

tel aviv, israel, sept. 05, 2024 (globe newswire) -- parazero technologies ltd. (nasdaq: przo) (the "company” or “parazero”), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircrafts, today announced that it has signed an agreement with bladeranger ltd. (tase: blrn) (“bladeranger”), a developer of a powerful cleaning payload for drones that is designed for inspection and washing of solar panels and tall buildings. the multi-phase agreement is valued at approximately $230,000.

MULTIMETAVERSE HOLDINGS LIMITED ANNOUNCES ESTABLISHMENT OF JOINT VENTURE

News

shanghai, aug. 28, 2024 /prnewswire/ -- multimetaverse holdings limited (nasdaq: mmv) ("mmv" or the "company"), a leading animation and entertainment company for young consumers in china, today announced the establishment of a new joint venture, gold abc digital technology co., limited ("gold abc"), and its initial strategic investments.

BTC DIGITAL LTD. ANNOUNCES STRATEGIC ACQUISITION OF ARKANSAS-BASED MINING FACILITY

News

shenzhen, china , july 3, 2024 /prnewswire/ -- btc digital ltd. ("btc digital" or the "company") today announced the signing of a significant acquisition agreement, marking the successful purchase of an arkansas-registered company.

BULLFROG AI TO PARTICIPATE AT THE H.C. WAINWRIGHT 26TH ANNUAL GLOBAL INVESTMENT CONFERENCE

News

gaithersburg, md., aug. 26, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a leader in ai-driven drug discovery, announced today that the company will participate in the h.c. wainwright 26th annual global investment conference being held in new york city.

AMERICAN SHARED HOSPITAL SERVICES REPORTS STRONG SECOND QUARTER 2024 FINANCIAL RESULTS

News

revenue increases 27% year over year reports gain of $3.7 million from strategic acquisition of rhode island radiation therapy cancer centers now treating patients at the new puebla, mexico center conference call on august 14 th at 6:30 pm et san francisco, aug. 14, 2024 (globe newswire) -- american shared hospital services (nyse american: ams) (the "company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the second quarter ended june 30, 2024. second quarter 2024 and recent highlights total revenue in the second quarter was $7.1 million, an increase of 27% from the comparable period in 2023 bolstered by the completion of our acquisition of 60% of the equity interest of three rhode island radiation therapy facilities in may which accounted for $1.9 million of the increase.

BANLE GROUP ANNOUNCES 2024 INTERIM RESULTS AT WEBCAST

News

cbl international limited (incorporated in cayman islands with limited liabilities) (nasdaq: banl) kuala lumpur, malaysia, sept. 04, 2024 (globe newswire) -- cbl international limited (the “company” or “cbl”) (nasdaq: banl), the listing vehicle of banle group (“banle” or “the group”), a reputable marine fuel logistic company based in the asia-pacific region, announced today it will file its interim report on form 6-k for the year ended june 30, 2024, on thursday, september 12, 2024.

MARIS-TECH RECEIVES U.S. PATENT FOR INNOVATIVE FORWARD ERROR CORRECTION OPTIMIZATION METHOD

News

the patented method reduces overhead data required in the forward error correction process based on specific characteristics of streamed media communication

SENIOR FINANCIAL EXECUTIVE JOINS INTELLICHECK

News

melville, n.y.--(business wire)---- $idn #authentication--intellicheck, inc. (nasdaq: idn), an industry-leading identity company delivering on-demand digital and physical identity validation, today announced that adam sragovicz has joined the company as a senior financial executive. the appointment of mr. sragovicz begins the transition of the leadership of intellicheck's financial organization. he will assume the position of cfo on september 1 upon the previously announced departure of jeff ishmael. as cfo, he will le.

HOTH THERAPEUTICS ANNOUNCES EXPANSION OF CLINICAL SITES FOR HT-001 PHASE 2A TRIAL

News

dana-farber cancer institute in boston, ma and montefiore medical center in new york, ny join clinical trial new york , sept. 5, 2024 /prnewswire/ -- hoth therapeutics, inc. (nasdaq: hoth), a patient-focused biopharmaceutical company, today announced today that it has received institutional review board approval from the montefiore medical center and the dana-farber cancer institute to proceed with its first-in-human (fih) phase 2a clinical trial of ht-001 for the treatment of skin toxicities associated with epidermal growth factor receptor inhibitors (egfri).

NIOCORP PROVIDES PRELIMINARY FINANCIAL RESULTS FOR THE FISCAL YEAR ENDED JUNE 30, 2024

News

centennial, co / accesswire / august 26, 2024 / niocorp developments ltd. ("niocorp" or the "company") (nasdaq:nb) today provided its preliminary financial results for the fiscal year ended june 30, 2024.

FORGE GLOBAL CEO TO FIRESIDE CHAT AT THE PIPER SANDLER & CO. GLOBAL EXCHANGE & TRADING CONFERENCE

News

san francisco--(business wire)--forge global holdings, inc. (“forge,” or the “company”) (nyse: frge), a leading private securities marketplace, today announced that kelly rodriques, chief executive officer, will participate in a fireside chat at the piper sandler & co. global exchange & trading conference. details for the event are as follows: where: piper sandler & co. global exchange & trading conference, new york, ny. when: wednesday, june 5th, 2024 time: 4:00 p.m. eastern ti.

TRUST STAMP ANNOUNCES PRICING OF REGISTERED DIRECT OFFERING AND WARRANT INDUCEMENT, PRICED AT-THE-MARKET, FOR AGGREGATE GROSS PROCEEDS OF $2.0 MILLION

News

atlanta, ga, sept. 03, 2024 (globe newswire) -- trust stamp (nasdaq: idai), the privacy-first identity company™ providing ai-powered software used globally across multiple sectors, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 1,432,399 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering priced at-the-market under nasdaq rules. in a concurrent private placement, the company also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 2,864,798 shares of common stock. the combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and accompanying warrant is $0.3223. the private placement warrants will be exercisable upon receipt of shareholder approval, will expire five years from the initial exercise date and will have an exercise price of $0.3223 per share.

ICAD REPORTS FINANCIAL RESULTS FOR SECOND QUARTER ENDED JUNE 30, 2024

News

nashua, n.h., aug. 13, 2024 (globe newswire) -- icad, inc. (nasdaq: icad) (“icad” or the “company”) a global leader on a mission to create a world where cancer can't hide by providing clinically proven ai-powered breast health solutions, today reported its financial and operating results for the three and six months ended june 30, 2024.

TREASURE GLOBAL INC STRENGTHENS LEADERSHIP WITH APPOINTMENT OF NEW INDEPENDENT DIRECTORS

News

new york and kuala lumpur, malaysia, sept. 03, 2024 (globe newswire) -- treasure global inc (nasdaq: tgl) (“treasure global” or the “company”), a leading technology solutions provider, is pleased to announce the appointment of two new independent directors, mr. leong wei ping and mr. anand ramakrishnan to its board. this strategic move underscores the company's ongoing efforts to strengthen its leadership team and enhance its corporate governance as it continues to scale its operations and expand its global presence.

PSYENCE BIOMED ANNOUNCES INITIATION OF FIRST TRIAL SITE IN AUSTRALIA FOR ITS PHASE IIB STUDY OF NATURE DERIVED PSILOCYBIN AS A POTENTIAL TREATMENT FOR ADJUSTMENT DISORDER IN PALLIATIVE CARE

News

patient screening to be initiated imminently; first subject expected to be randomized into the study in october patient screening to be initiated imminently; first subject expected to be randomized into the study in october

DIGIASIA CORP. APPOINTS ANDREAS GREGORI TO ITS AI STRATEGIC ADVISORY BOARD

News

~ the addition strengthens the delivery of meaningful ai fintech solutions for its enterprise clients ~ new york, aug. 20, 2024 (globe newswire) -- digiasia corp. (nasdaq: faas) (“digiasia” or the “company”), a leading fintech as a service (“faas”) ecosystem provider, today announced that andreas gregori, a current member of digiasia's board of directors and highly experienced business executive and entrepreneur, has been appointed as an advisor to its recently established ai strategic advisory board. mr. gregori is a seasoned commercial leader with a digital and customer-first mindset.

SONOMA PHARMACEUTICALS ANNOUNCES 1-FOR-20 REVERSE SPLIT OF OUTSTANDING COMMON STOCK

News

boulder, co / accesswire / august 28, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the timing for a 1-for-20 reverse split of its outstanding common stock which will be effected on august 29, 2024 at 5:00 pm edt. sonoma common stock will begin trading on the nasdaq capital market on a 1-for-20 adjusted basis when the market opens on august 30, 2024.

ZEO ENERGY CORP. TO PRESENT AT THE 2024 GATEWAY CONFERENCE ON SEPTEMBER 5ᵗʰ

News

new port richey, fla., aug. 22, 2024 (globe newswire) -- zeo energy corp. (nasdaq: zeo) (“zeo”, “zeo energy”, or the “company”), a leading florida-based provider of residential solar and energy efficiency solutions, is confirmed to present at the 2024 annual gateway conference , which is being held september 4-5, at the four seasons hotel in san francisco, ca.